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i 
Abstract 
 
Background 
Delirium, an acute neurobehavioral syndrome, occurs across all healthcare settings and is 
suggested to be the most common psychiatric condition experienced by older 
hospitalised patients. It affects around a fifth of those in general medical wards with 
higher prevalence in surgical and intensive care unit patients. 
Delirium and chronic cognitive impairment share a complicated two-way relationship. 
Those with dementia are at greater risk of developing delirium while length of delirium 
episode is also associated with increased risk of long-term cognitive decline. Delirium is 
associated with a number of other serious negative outcomes including increased risk of 
falls, institutionalisation and mortality. Identification of delirium in hospitalised older 
patients is necessary to facilitate good patient care as well as to allow for the appropriate 
support for concerned relatives and carers.   
Guidelines are in general agreement that screening for delirium and cognitive impairment 
is important in hospitalised, older patients. Identification of delirium is the first necessary 
step to then allow for the management of this syndrome. However, there are a wide 
range of screening tools available for cognitive impairment and delirium with limited 
research evidence or validation of these tools in large, representative cohorts. 
Furthermore, clinical awareness of delirium is low compared to many other conditions; 
this may be improved by implementing clear delirium screening guidelines along-side the 
necessary training.  
Methodology 
Before delirium screening tools can be implemented in routine practice, an evidence-
based approach should be followed to assess feasibility and diagnostic accuracy within 
older in-patient cohorts.  
In this thesis, I investigate screening for cognitive impairment systematically in a series of 
linked studies. I review the existing published evidence as well as investigating screening 
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for delirium in older, acute medical units locally and nationwide. I collate existing 
evidence for the use of brief screening tools for delirium, dementia and mild cognitive 
impairment (MCI) across healthcare settings. I also carry out analysis of an existing data 
set looking at the feasibility and accuracy of two single questions for delirium and 
dementia, separately. Furthermore I gather data relating to cognitive screening from lead 
clinicians across hospital sites within elderly acute care units in Scotland. I also carry out a 
local service evaluation to determine documented delirium prevalence as well as what 
tools were being used to screen for cognitive impairment and delirium. These results 
inform a diagnostic test accuracy evaluation of delirium and cognitive impairment 
screening tools recommended for routine clinical use with acute care in-patients. This 
evaluation is in a relatively large-scale, representative sample and assesses the feasibility 
as well as accuracy of these tools against a gold standard clinician diagnosis of delirium. 
My diagnostic test accuracy evaluation was based on a clear local problem of lack of 
routine delirium screening in older in-patients and aimed to inform future 
recommendation policy by examining which tools are feasible and accurate within this 
setting.  I also aimed to add to the existing delirium screening evidence base by 
examining a range of recommended tools within a large, consecutive patient cohort. This 
was contrary to much of the published literature which generally examine one screening 
tool and often within small or case-controlled patient samples.  
This evaluation of screening tools for the assessment of possible delirium within the 
acute care setting examined the feasibility and test accuracy of cognitive tests which 
were recommended by clinical guidelines for both delirium and cognitive impairment. 
The tests evaluated were the Abbreviated Mental Test (AMT 10/4), the 4 A’s Test (4AT), 
the brief Confusion Assessment Method (bCAM) (a rapid, operationalised version of the 
Confusion Assessment Method (CAM)) and the Single Screening Question in Delirium 
(SQiD). I also explored the performance of reciting months of the year backwards 
(MOTYB), present as part of both the 4AT and bCAM. All screening tests were compared 
to gold standard diagnosis using delirium criteria from the Diagnostic and Statistical 
Manual of Mental Disorders – fifth revision (DSM 5) which was completed by senior 
geriatricians.  
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Findings 
My systematic literature review revealed heterogeneity of methods in the published 
evidence for very brief, single item cognitive screening tools. However my secondary data 
analysis revealed high sensitivity for a single informant question for dementia and 
reasonable sensitivity for a single question for delirium.  
The clinician survey showed a lack of consensus regarding the choice of screening tools 
used for delirium and dementia at a national (Scottish) level. Within geriatric units in 
Scotland there appears to be notable variability in the way delirium screening is carried 
out.  The clinician survey revealed a particular issue for delirium screening in the West of 
Scotland where there appears to be a lack of standardised tools used to screen for 
delirium. Furthermore, local ward service evaluation revealed a lack of documentation of 
delirium diagnosis with little awareness of delirium across acute elderly wards within a 
large teaching hospital in Glasgow. 
Evaluation of cognitive impairment screening tools found that the AMT 10, AMT 4, 4AT 
and MOTYB were feasible and accurate tools for the assessment of delirium within a 
cohort of 500 acute in-patients age > 65 years. The AMT 10 was found to have reasonable 
sensitivity at a cut point of <4/10 and the AMT 4 was found to have good sensitivity at a 
cut point of <3/4; use of the full 10-point AMT seemed to carry no substantial advantage 
over the shorter AMT 4. The bCAM was found to have poor sensitivity, missing 3 in 10 
cases of delirium. I did not find the informant-based SQiD to be feasible in this population, 
with a return rate of 28%, but displaying a sensitivity of over 90%. These results suggest 
that a range of tools exist which display good diagnostic test accuracy and feasibility in an 
older, acute care in-patient cohort.  These can all be completed quickly and are simple to 
administer. Informant information using a standardised single screening question (SSQ) 
such as the SQiD may still hold value in aiding the diagnosis of delirium when this can be 
obtained. 
Conclusions 
In conclusion, the studies in this thesis aim to add to the pool of literature available for 
the screening of delirium and cognitive impairment. I used a logical and informed 
ordering of the research conducted. The results from my systematic review, secondary 
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data analysis, clinician survey and service evaluation all fed in to the planning of my 
clinical patient evaluation of delirium screening. Results from my literature review and 
data analysis did not discount the use of a single question to screen for delirium but did 
suggest a need for further research with a gold standard clinician diagnosis for 
comparison. My clinical evaluation results revealed that relatively accurate screening of 
delirium is possible using existing, simple and brief screening tools which are already 
suggested in guidelines for routine clinical use.  
Screening for delirium should be regarded as a first step in the care pathway for those 
who are identified as having possible delirium. The value of delirium screening depends 
on the implementation of specific care pathways for those who then go on to receive a 
clinical diagnosis of delirium.  Patients with delirium have an increased risk of falls, 
dehydration and infection alongside the associated long-term complications. Good 
patient care should aim to cater to these patients’ specific needs in the same way it does 
with other medical conditions.  
Healthcare Improvement Scotland (HIS) recommends all older patients should be 
routinely screened for delirium but acknowledges that this is not the case, with delirium 
being ‘frequently overlooked or misdiagnosed’. It may not be enough to make these 
recommendations without implementing a system of education to promote and raise 
awareness for the importance of screening for delirium.  
I suggest that further research is needed to assess the accuracy and feasibility of delirium 
screening tools for older, acute care in-patients while implementing a care pathway for 
patients who are then diagnosed with delirium. This would inform the best possible 
future care for patients with delirium. The potential for improved outcomes for these 
patients is also of interest. Evaluation of interventions in large scale, representative 
patient samples are needed to further progress our knowledge of treatment of delirium 
as a serious and often overlooked disorder of the brain caused by physical illness.  
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Chapter 1: Background and literature review 
 
1.1 What is delirium? 
1.1.1 History of delirium 
The word ‘delirium’ comes from the Latin word ‘deliro-delirare’ which translates as ‘to go 
out of the furrow’ [1]. Documentation of the terminology ‘delirium’ exists as far back as 
the first century AD in medical writings by Celcus [2], to describe mental impairment 
occurring during fever and trauma to the head. Celcus gave insight in to the nature of 
delirium by describing that while the cause of the syndrome may be resolved, patients 
may still continue to appear ‘insane’ [3].  
A more detailed description of delirium was provided by historian Procopius [4] AD 542 
when explaining a possible bubonic disease in Constantinople. He described what would 
likely be referred to as hyperactive delirium today; insomnia, violent outbursts, 
excitement, physical over-activity and shouting. He also explained a different subset of 
symptoms, resembling the modern day concept of hypoactive delirium; comatose state, 
long periods of sleep, unable to take care of basic needs such as food and water as well as 
forgetting familiar people. Procopius also explained that individuals often experienced 
hallucinations before the onset of this possible bubonic disease.  
There have been many other writings and observations regarding delirium with a variety 
of different names throughout the ages. For example, Hippocrates used sixteen different 
names to refer to what we now understand to be the clinical syndrome of delirium 
including ‘leros’, ‘mania’, ‘lethargus’ and also ‘phrenitis’ which dates back as far as 500 BC 
[5]. ‘Phrenitis’ was also referenced in writings by Celcus as an alternative to delirium [2]. 
There was general consensus that this disorder of the mind was associated with poor 
clinical outcomes [3]. However, despite this long history of descriptions relating to 
delirium, it still remains a poorly understood and difficult to define disorder.  
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1.1.2  Other names for delirium 
A range of other names are used for the syndrome of delirium. Such names include [6]; 
• “Intensive Care Unit psychosis” - indicating the high incidence of delirium within 
this hospital setting. 
• “Sundowning” – as it is said that delirium symptoms become more apparent when 
the patient is under stimulated, such as at night. 
• “Acute confusional state” and “acute brain failure – commonly coined in the 
medical and psychiatric literature. 
This lack of one solitary term may create uncertainty about the epidemiology of the 
syndrome. 
 
1.1.3 Delirium subtypes 
Delirium symptoms can be categorised in to three subtypes [7]; 
• Hyperactive – The patient expresses heightened levels of arousal with possible 
restlessness, aggression and agitation. 
• Hypoactive – The patient is withdrawn, quiet and tired. 
• Mixed – The patient shows a combination of the symptoms associated with 
hypoactive and hyperactive delirium across the course of a delirious episode. 
The identification of a subtype can have utility in the clinical setting as each subtype is 
met with its own unique complications. Patients with hyperactive delirium are at greater 
risk of falls while those with hypoactive delirium, in addition to falls, are also prone to 
hospital-acquired infections [8]. Hypoactive delirium is the most common presentation of 
the disorder; evidence suggests that hypoactive delirium may be associated with higher 
mortality than those with hyperactive or mixed delirium [9]. However, hypoactive 
delirium can often go undetected with 78.3% of hypoactive delirium cases missed within 
the emergency department setting, despite hypoactive delirium accounting for up to 92% 
of all cases of delirium [10]. Prevalence of hypoactive delirium varies widely between 
studies and across hospital settings [11] (Table 2). 
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Assessment tools exist for the assessment of delirium sub-type such as the Delirium 
Motoric Checklist [12] which contains four items relating to hyperactive delirium 
(including restlessness and wandering) and seven items relating to hypoactive (such as 
decreased amount of activity and decreased speed of actions) with two symptoms 
needed to meet subtype inclusion. A patient is considered to have mixed delirium if there 
are motor disturbance symptoms present from both categories.  
 
1.1.4 Diagnostic classification 
Gold standard diagnostic criteria provide a list of symptoms which can be operationalised 
in clinical practice to make a diagnosis of any given disorder. These criteria exist to allow 
for standardisation of diagnosis across settings. As such, it is may be deemed important 
that any screening test should reflect the gold standard. Below is a summary of the main 
published criteria used for the diagnosis of delirium.  
Diagnostic and Statistical Manual of Mental Disorders – Fifth edition (DSM-5) 
The Diagnostic and Statistical Manual of Mental Disorders is published by the American 
Psychiatric Association (APA) and serves as a mode of standardising diagnostic criteria for 
the classification of mental disorders. The first edition [13] was published in 1952, with 
the fifth and most recent revision published in 2012, namely the DSM 5 [14]. 
The DSM 5 defines delirium using 5 criteria; 
a) A disturbance of attention (directing, focusing & shifting) and awareness of the 
environment. 
b) The disturbance develops acutely (within a few days) and is representative of a 
change from baseline in attention and awareness, with fluctuating course over 
any 24 hour period.  
c) An additional disturbance of cognition is also apparent, such as memory problems, 
disorientation, language deficit or changes in perceptions.  
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d) A and C cannot be better explained by another disorder in cognition (pre-existing, 
established or evolving) and do not occur during an episode of severe reduction in 
level of arousal e.g. coma.  
e) Evidence from the patient’s history, physical exam or lab tests suggests that the 
disturbance is a direct physiological consequence of a medical condition, 
substance abuse/withdrawal, exposure to a toxin or multiple etiologies. 
International Classification of Diseases and Related Health Problems- 10
th
 Revision (ICD-
10) 
The ICD was developed by the World Health Organisation (WHO) as a standard tool for 
diagnosing a broad range of clinical conditions. The ICD-10 [15] describes delirium as 
being more common in those aged 60 and over, with a transient and fluctuating nature 
which tends to resolve within four weeks. This criterion defines delirium according to 5 
domains;  
a) Impaired consciousness and attention (shifting, sustained and focused).   
b) A global disturbance of cognition including perceptual disturbances, delusions and 
hallucinations, impaired abstract thinking and comprehension, impaired 
immediate recall and recent memory, disorientation to time, place and/or person.  
c) Psychomotor disturbance which can be over or under active with fluctuation 
between the two.  
d) Sleep-wake cycle disturbance including insomnia and/or over sleeping.  
e) Emotional disturbance such as depression, irritability, aggression or anxiety.  
Confusion Assessment Method (CAM) 
The CAM was developed as a tool which would allow non-psychiatric clinical staff to 
diagnose delirium with ease [16]. This development was based on systematic review and 
expert consensus and was originally validated against a now outdated version of the DSM, 
the DSM IIIR [17]. To assess for delirium, the CAM uses nine assessment criteria based on 
diagnostic features of delirium (Table 3). This diagnostic assessment tool relies on 
subjective clinician judgement on a range of cognitive abilities including inattention, 
disorientation and memory impairment and provides different formats of response 
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including rating scale and open-ended response. A shorter, four item CAM also exists for 
more brief assessment of delirium (highlighted within Table 3). Research suggests that 
the CAM has a high sensitivity and specificity when used by trained individuals and has 
shown to be popular for use within the clinical and research setting since its development 
[18].  
 
1.1.5 Risk Factors 
Predisposing factors are those which render an individual vulnerable to becoming 
delirious. These include demographic factors such as old age, which is significantly 
associated with increased risk of delirium [19-20]. Dementia is also significantly 
associated with risk of becoming delirious across a range of settings [21]. There is 
evidence to suggest that patients with depression are significantly at risk of delirium [22]. 
Illness severity and co-morbidity, as measured by the assessment tool the Acute 
Physiology and Chronic Health Evaluation (APACHE II) scale, are commonly reported as 
significant delirium risk factors [20, 23]. Furthermore, functional impairment, specifically 
impairment in activities of daily living skills and immobility were also found to be 
significantly associated with risk of delirium although these impairments are not direct 
risk factors but reflect another causal factor such as infection or falls [20-21]. 
Precipitating factors are newly introduced conditions which trigger onset of delirium. The 
precipitating factors found to most strongly associate with delirium were use of a urinary 
catheter, introduction of psychoactive medications and infection [24]. 
 
1.1.6 Neuropsychology of delirium  
Neuropsychological profiling of delirium involves using appropriate cognitive assessments 
to establish the cognitive domains affected before, during and/or after the course of a 
delirious episode. While it is accepted that disturbance of cognitive processes is a 
defining feature in those with delirium, few research publications exist examining the 
neuropsychological profile of delirium. Establishing this may allow for clinicians to 
correctly differentiate delirium from other disorders with overlapping symptoms such as 
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MCI, dementia and aphasia as well as detecting less severe delirium [25]. Thus, possibly 
reducing rates of misdiagnosis and increasing detection rates. Furthermore, delirium 
screening tests should measure the cognitive domains affected in delirious patients.  
Most studies investigating impairment of cognition in delirium focus on that of fluid 
cognitive abilities. Fluid cognition involves the active processing, manipulating and 
maintaining of neural information such as tasks relying on the maintenance of attention, 
known to be impaired in delirium [26]. In contrast, crystallized cognition relies on 
information stored through previous learning and experience such as vocabulary, 
grammar and general knowledge [27].  Crystallized and fluid cognition are reliant on 
different areas of the brain and as such affected in different ways by neural events. 
Crystallized cognition is also shown to be more stable through-out the lifetime, compared 
to fluid cognition which shows steady decline in to old age [27]. Brown et al [26] 
attempted to establish if crystallized cognition is affected in patients with delirium, in 
comparison to fluid cognition. This was done by measuring crystallized and fluid cognition 
before and after planned cardiac surgery. It was found that while patients demonstrated 
extensive impairment on high demand tests of fluid cognition such as digit span and 
Stroop tests, crystallized abilities were preserved as measured by the National Adult 
Reading Test [28]. These results suggest crystallized intelligence may provide a measure 
of level of cognitive function prior to neural insult such as delirium. This may be 
particularly useful in cases where a relative or carer is not available to provide a history of 
the patient’s baseline level of cognitive functioning.  
A small number of studies exist which attempt to profile the neuropsychology of delirium 
by measuring domains of fluid cognitive abilities. Meagher at al. [29] and Leonard et al. 
[30] investigated the domains impaired in delirious patients using the Cognitive Test for 
Delirium (CTR) [31]; a tool which measures the patient’s attention span, orientation, 
memory, comprehension/reasoning and vigilance. Both studies found impairments in the 
domains of attention, vigilance and orientation (visuospatial abilities). Longitudinal 
assessment of cognition revealed that impairments in attention, memory and working 
memory first became apparent 4 days prior to delirium diagnosis [32].  
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Further investigation in to the neuropsychological profile of delirium across the course of 
delirium in a cohort of planned transplant patients found deficits in the domains of 
attention/working memory, psychomotor speed, memory as well as learning [32]. 
Patients were assessed 10 days pre-transplantation to establish baseline cognitive 
functioning as well as for the duration of their hospitalisation post-transplantation (up to 
4 weeks). During the post-transplantation assessment phase, no patients who 
experienced a delirium returned to baseline cognitive functioning during this time. 
Cognitive performance across tests showed a mild decline directly prior to the onset of 
delirium and a sharp decline with delirium diagnosis and fluctuating performance 
following this. This evidence suggests that clinicians may be able to predict delirium onset 
through profiling of cognitive symptoms with possible implications for prevention. 
Changes in cognitive function of patients may aid the monitoring and early detection of 
delirium.   
Impairment to attention is now accepted as a core diagnostic feature of delirium [33]. 
Research suggests that patients with delirium show impairment on various types of 
attention, including attention span, selective attention and sustained attention [26, 34-
35]. However, there appears to be a particular deficit in sustained attention in these 
patients [33]. Sustained attention is the ability to attend to specified stimuli over a period 
of time [36]. 
While inattention as a core feature of delirium is relatively well represented within the 
literature, level of arousal is less well documented. Abnormal level of arousal is important 
within the clinical setting as it is associated with increased illness severity, is a strong 
predictor of increased mortality [37] as well as an indicator of the presence of delirium 
[36]. Furthermore, abnormal level of consciousness is associated with poor performance 
on tasks of sustained attention [36]. 
Posner’s original model of attention developed over 30 years ago suggests that attention 
and arousal are closely linked and the model explains how the brain decides which stimuli 
it attends to within our stimuli-intensive environment [38]. Posner proposed that our 
attention network within the brain comprises of three separate but fully-integrated 
systems; Alerting, Orienting and Executive Function. It is explained that the Alerting 
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Network is responsible for maintaining optimal arousal and observes but is not 
responsible for taking action. When the alerting network switches from observing general 
environment changes to monitoring specific features, the Orienting Network is triggered. 
Posner explains that at this point all the senses are alerted and the orienting network is 
responsible for prioritising information received by the senses. This then triggers the 
Executive Network.  Here it is decided if the individual should maintain focus on the 
selected stimuli and, if so, then the processing of other available targets slows down.  
When thinking about delirium in terms of Posner’s model of attention it would appear 
that individuals with delirium have a deficit to all three attention networks, displaying an 
inability to maintain focus during a task (alerting), an inability to prioritise sensory input 
(orienting) and the inability to maintain attention on a specific target while attending less 
to competing targets (executive control).   
 
1.2 Why does delirium matter? 
1.2.1 Psychological impact 
Delirium can be a distressing experience for the patient as well as relatives, carers, 
friends and the staff responsible for the care of the patient.  
The distress caused by delirium can continue for the patient once it has resolved as the 
individual recollects memories from delirious episodes, with the possibility that the 
patient is unable to differentiate between factual and delirious memories [39]. 
Furthermore, delirious recall may have further negative repercussions as it has been 
associated with symptoms of post-traumatic stress disorder [40-41] as well as anxiety and 
depression [42-43].  
From current literature, it is unclear what proportions of patients are able to recall 
memories following delirium due to small sample sizes, qualitative data collection and a 
wide variety of figures reported. For example, one study reported that the majority of 
patients did not recall memories of delirium [44] while others have stated that more than 
half of patients were able to recall some memories of being delirious when interviewed 
[45-46]. A study conducted within an oncology in-patient setting found that 54% of 
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patients who had been diagnosed with delirium were able to recall this episode. Of these 
patients, 80% rated this experience as severely distressing [47]. Evidence suggests that 
distress level is not affected by delirium sub-type [47-48].  
It is also important to consider the distress experienced by relatives and carers of patients 
with delirium. A study which assessed the occurrence of generalised anxiety in caregivers 
of patients with cancer found that the incidence of generalised anxiety was 3.5% [49]. 
Caregivers who reported the patient had recently had delirium were 12 times more likely 
to have generalised anxiety than those who had not experienced observing delirium or 
confusion. This relationship still existed when caregiver demand was adjusted for.  
Delirium may also have a negative impact on nursing staff who are the individuals in 
closest contact with in-patients suffering from delirium. Literature reviews evaluating the 
effects of delirium on nursing staff identified themes emerging from qualitative studies 
[50-51]. These include; ‘stress due to unpredictability of delirium and workload’, ‘issues 
of safety’, ‘difficulties reaching patients’, ‘care environment not meeting needs of older 
adults’ and ‘patients being suspicious of nursing staff’. Furthermore, a survey of 101 
nursing staff responsible for the care of cancer patients with delirium found that 73% of 
staff suffered severe distress with the strongest predictors of distress experienced by 
nursing staff being delirium severity and perceptual disturbances [47]. 
 
1.2.2 Cognitive impairment 
Delirium is recognised as an indicator of increased risk of chronic cognitive impairment in 
older people and even those without prior cognitive or functional issues [52]. This is 
further explored in section 1.3.2.  
 
1.2.3 Persistent delirium 
Evidence suggests that delirium can continue up to six months following the patient’s 
discharge [53]. Longitudinal analyses have revealed that for older patients diagnosed with 
delirium during hospitalisation delirium persisted in almost half of these patients at 
discharge, a third at one month, a quarter at three months and a fifth at six months post 
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discharge [54]. This suggests that in a substantial number of older patients, a full recovery 
may not be made from an episode or multiple episodes of delirium during hospitalisation. 
This may account, at least in part, for the poor outcomes of patients with delirium and 
supports the need for the prevention as well as quick detection of delirium. 
 
1.2.4 Complications of health care 
Patients with delirium are at a greater risk of suffering from a range of negative health 
care outcomes including falls, prolonged hospitalisation, pressure sores and dehydration 
during hospitalisation [55] and as a result greatly increased health care costs. 
1.2.5 Functional impairment 
Research has shown that those who recovered quickly from an episode of delirium had 
notably better functional recovery than those with persistent delirium in a sample of 
patients recovering from hip fracture assessed 2-7 days after the fracture occurred [56]. 
Furthermore, duration of delirium is associated with poorer scores on Katz Index of 
Independence in Activities of Daily Living (IADL) [57] as a measure of the patient’s 
functional ability on normal daily tasks including personal hygiene, feeding self, home 
maintenance and dressing self [58]. 
Delirium is also associated with increased long-term nursing home placements following 
hospital discharge [59].  
 
1.2.6 Death 
Mortality is high in those with delirium with up to 14% of those patients dying within a 
month of delirium diagnosis and rising to 22% after six months; twice that of patients 
with comparable medical conditions but absent of delirium [60]. 
Furthermore, length of delirium episode has also been associated with mortality with 
research revealing that mortality increased by 11% per 48 hours of active delirium [61].  
 
11 
1.3 How does delirium differ from other cognitive impairment?  
1.3.1 Mild cognitive impairment (MCI) 
MCI occurs when an individual presents with cognitive impairment which meets some 
but not all diagnostic criteria of dementia but is an impairment greater than that 
explained by normal cognitive ageing [62]. Unlike delirium, MCI does not have an acute 
onset and is thought to have a progressive nature. According to commonly used criteria 
[63], to meet conditions for MCI, one must;  
i) Present with memory problems 
ii) Have normal activities of daily living 
iii) Have normal general cognitive function 
iv) Present with abnormal memory relative to age 
v) Not meet dementia diagnostic criteria 
vi) Show impairments in cognitive domains other than memory.  
 
1.3.2 Dementia 
Unlike delirium, dementia is a chronic, progressive form of cognitive impairment which 
represents a change in one or more cognitive domains reducing an individual’s ability to 
carry out day-to-day tasks [64]. While delirium is characterised by fluctuations in the 
cognitive domains of inattention and level of consciousness, these domains usually 
remain intact until the later progression of dementia. However, a two way relationship 
exists where-by those with a pre-existing dementia are more likely to get delirium and, 
vice versa, patients whom experience delirium are more likely to go on to develop a 
dementia. The occurrence of delirium along-side dementia is high among hospitalised 
older adults (22-89%). [65] 
However, the relationship between dementia and delirium is poorly understood. It is 
unclear why those who get delirium are more likely to go on to develop a dementia. 
Existing explanations include [66]; 
i) Delirium may be symptomatic of a patient’s vulnerability to dementia.  
ii) Delirium may reveal an existing, unrecognised long term cognitive impairment. 
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iii) Delirium may lead to neuronal damage and thus be directly responsible for 
causing dementia. A number of ways in which neuronal damage could occur 
have been hypothesised. These include increased exposure to anti-psychotic 
drugs, chronic stress, inflammation, infection or ischemia.  
It can often be difficult to differentiate between delirium and dementia in the clinical 
setting due to overlap in symptoms. This is particularly true in the case of Lewy body 
dementia with notable overlap in clinical presentation including hallucinations and 
fluctuation of the symptoms experienced as characteristic of both disorders. 
1.4 Is delirium preventable? 
Delirium is the result of an underlying medical condition and is suggested to be evidence 
of the vulnerability of the aging brain to bodily insults. The causes of delirium span across 
different levels and include [53]; 
i) Pre-disposing factors such as chronic cognitive impairment, sensory 
impairment and immobility. 
ii) Environmental factors such as lack of sleep due to noises from machines, staff 
and other patients through the night as well as lack of orientation to time.  
iii) Acute physiological factors such as dehydration, infection (for example urinary 
tract infections and pneumonia), catheterisation and inflammatory response. 
It would be logical to assume that if incidences of these factors are reduced or, better yet, 
prevented where possible then cases of delirium would also be reduced.  
Systematic literature review was carried out to determine the effectiveness of non-
pharmacological and pharmacological interventions aimed at the prevention and/or 
management of delirium in older individuals [67]. This review looked specifically at 
interventions published as randomised controlled trials (RCT), pivotal trials, systematic 
reviews or meta-analyses. The non-pharmacological studies highlighted by this review are 
summarised in Table 4 [68-73].  
Furthermore, a recent Cochrane review collated the available evidence from all 
randomised controlled trials of delirium prevention interventions [74]. Results revealed 
that multi-component interventions significantly reduced incident delirium compared to 
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usual care, although this effect was uncertain in patients with a prior dementia.  This 
review provides strong evidence for the further exploration of multi-component delirium 
prevention interventions in representative samples.  
Pharmacological interventions have been found to have varied success in both the 
prevention and treatment of delirium in older adults. 
Meta-analysis revealed that the short-term use of anti-psychotic medications may reduce 
the incidence of delirium with no reported harmful effects [75]. Anti-psychotics have also 
been shown to have potential utility in reducing the severity and length of delirium 
episodes in older adults, reducing the need for physical restraints or further interventions 
[76]. 
A meta-analysis of evidence relating to the preventative and treatment benefits of 
cholinesterase inhibitors in older people with delirium revealed this intervention was not 
beneficial compared to placebo [77].  
Furthermore, melatonin use may prevent episodes of delirium and has also been shown 
to be potentially beneficial in the management of symptoms [78]. 
However, when weighing up the evidence of interventions in older people for the 
prevention of delirium, structured analyses of 10 RCT’s has revealed no difference in the 
use of pharmacological vs. multi-component vs. one-component interventions [79]. 
1.5 Assessing delirium in older patients 
1.5.1 Criteria for an effective screening programme 
To assess if a screening programme is a necessary step in any health-related disorder, a 
number of points should be considered. The World Health Organisation (WHO) has 
developed a list of criteria which should be met to ensure the validity of a screening 
program [80]. The condition should be; 
• An important health concern 
• Well understood 
• Detectable at an early stage  
• Treatable and treatment at an early stage should have more benefit than when the 
disorder has progressed further 
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Furthermore; 
• There should be an existing screening tool which is suitable for detection of the 
disorder at an early stage 
• It should be understood how often the screening test should be repeated 
• It should be possible for measures to be put in place to manage the extra workload 
created by screening this condition 
• The physical and psychological risks should be deemed less than the benefits  
• The costs should be economical with respect to the costs of medical care as a whole 
The UK national screening committee have outlined more detailed criteria for appraising 
the viability, effectiveness and appropriateness of a screening programme [81]. This takes 
in to account many of the aspects outlined by WHO as well as extra criteria relating to the 
condition, test, treatment and the screening programme itself. This set of criteria goes in 
to greater detail on the actual screening programme (including screening, diagnosis and 
treatment) and implementation of this for any specified disorder. It states there should 
be high quality empirical evidence in support of a screening programme showing 
reduction in mortality and morbidity; the programme should be clinically, socially and 
ethically acceptable; the screening programme should meet a set of quality assurance 
standards; patients should be provided with evidence-based information of the risks 
associated with this screening programme to allow them to make an informed decision.   
1.5.2 Epidemiology of delirium 
Delirium is a common, serious disorder within older adults in the acute care setting. 
Meta-analysis has revealed that in a non-selected cohort of older people, prevalence (the 
number of cases of delirium that are present in a selected population at any one time) of 
delirium is found to be uncommon in community dwelling individuals aged 65 and over at 
1-2%, with this prevalence rising in those age 85 and over to 11-12% [82]. This suggests 
that the risk of delirium associated with older age (>65 years) is low within the 
community.   
As well as those over 85, long-term care and dementia are also identified as groups of 
older individuals at high risk of delirium [83]. Another group of older people at higher risk 
of presenting with delirium are those in the acute care setting with a point-prevalence of 
approximately 20% and the disorder is particularly prevalent in those with a prior 
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dementia [84]. Older in-patients are at high risk of delirium with risk of delirium during 
admission found to be 3% for those under 65, 14% for those aged between 65 to 74 and 
rising to 36% for patients over 75 years old within the acute care setting [85]. 
Incidence rates (the number of new cases of delirium that develop across a specified 
period of time) of delirium in acute care vary widely within the existing literature. Pooled 
findings of 11 studies concerned with delirium in the acute care setting found incidence 
rates to vary from 5-38% [24].  
Delirium is under-recognised and often misdiagnosed across hospital settings. One study 
described clinical staff correctly identifying only 23% of delirium cases [86]. The ‘ideal’ 
delirium screening tool for hospitalised patients should have a high level of sensitivity, be 
quick and require little/no training to be administered [87]. 
 
1.5.3 Delirium screening guidelines within the United Kingdom 
The National Institute for Health and Care Excellence (NICE) provide evidence based 
information resources to aid day-to-day medical practice. The NICE delirium guidelines 
provide a pathway with the aim to aid the detection, treatment and prevention of 
delirium [7]. Firstly, the pathway asks; ‘Is the patient at risk of delirium?’ NICE guidelines 
highlight 4 groups of individuals as at-risk of delirium; 
i) Those 65 years and over 
ii) Individuals with cognitive impairment/dementia 
iii) Hip fracture patients 
iv) Those with a severe/deteriorating illness 
The pathway then goes on to ask; ‘Does the patient show any indicators of delirium?’ 
These indicators are highlighted as, a change in cognitive function such as lack of 
concentration or confusion, a change in physical abilities, a change in social functioning as 
well as auditory or visual hallucinations. The guidelines state that these indicators may be 
reported by the patient, carer or a relative. No specific screening tool is recommended 
for the assessment of these indicators. If any of these indicators are present then the 
NICE guidelines recommend that the patient receives a full diagnostic assessment. To do 
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this, NICE recommends using either the CAM or DSM-IV criteria (these guidelines were 
published before the currently most up-to-date criteria were published; DSM 5).  
HIS worked in collaboration with the Scottish Delirium Association and National Health 
Service (NHS) Scotland to develop resources to be used by medical professionals in the 
clinical setting. One such resource developed by Healthcare Improvement Scotland (HIS) 
as part of the ‘Older People in Acute Care Programme’ and ‘Think Delirium’ initiative is 
the ‘delirium toolkit’ which provides a flow diagram on how to identify, manage and treat 
delirium, with particular recommendations on the tools to be used [88]; 
• Step 1: Identify if there is a history of acute change in mental status. 
• Step 2: Use local delirium screening tool (suggests 4AT or CAM).  
• Step 3: Identify possible underlying cause (e.g. infection, medication) 
• Step 4: Obtain informant history (e.g. IQCODE, AD8) 
• Step 5: Record cognition/arousal level (e.g. MoCA, GPCOG, AMT 10, AMT 4)  
• Step 6 onwards: Treatment/ management if necessary.  
 
1.5.4 Screening tools for delirium 
Prior to carrying out diagnostic assessment of delirium, which would be very time 
consuming and not feasible to complete on every patient, a brief screening tool should be 
used to identify those with possible delirium while excluding those not at risk of having 
delirium.  
There are a wide range of screening tools for delirium available, which require direct 
patient assessment, clinician assessment, informant input or a combination of these. 
Many of these assessments have received some form of validation but the lack of 
consensus may make it difficult for clinicians to know which tool to use across different 
contexts. A recent systematic review identified validation studies of delirium screening 
tools used in hospital inpatient cohorts [89]. Table 5 [90-107] summarises the tools 
identified by this review, omitting screening tools developed specifically for the intensive 
care unit setting. The screening tools identified by this review ranged in length from a 
single question [106] to lengthy, multi-domain tools [90-91, 95-96, 101,103] with varying 
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demand on the patient, relatives and clinicians. These tools were validated across a range 
of hospital settings including the emergency department [91], oncology [106], 
rehabilitation [95] and geriatric in-patients [108] as well as across a number of countries 
making it difficult to generalise research findings across all patient cohorts and cultures. 
Thus, the existing evidence makes it difficult to select a single gold standard screening 
test for delirium. Of all the screening tests identified by this systematic review, the CAM 
was found to be the most commonly used delirium screening tool despite this 
assessment requiring extensive training to ensure good performance, often being 
regarded as a diagnostic tool as well as being based on out-dated delirium diagnostic 
criteria [89]. 
 
1.6 Thesis summary and aims 
The aims of this thesis are; 
i) To systematically determine the existing research on very brief cognitive 
screening assessments.  
ii) To determine what is currently used to screen for delirium and cognitive 
impairment locally and nationally. 
iii) To evaluate the use of very brief screening tests for delirium and cognitive 
impairment in older patients in acute hospital care. 
 
This will be investigated using a three part approach. The first part will look at existing 
research relating to the use of very brief screening tools (single questions) for delirium 
and cognitive impairment. The second part will focus on the evaluation of what is being 
done locally and nationally. The third part will evaluate delirium screening tools 
recommended by government and local guidelines for routine clinical use in older 
hospitalised individuals.  
Chapter 2 and 3 will investigate the simplest form of screening assessment for delirium 
and cognitive impairment, SSQ’s, through systematic review of the existing literature 
within this area (chapter 2) as well as analysis of an existing data set (chapter 3). Chapter 
2 aims to give a more in-depth understanding of screening for delirium and cognitive 
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impairment while establishing if this can be effectively done through use of a very brief 
tool or if more complex assessment is necessary. Chapter 3 will further build on this 
through diagnostic test accuracy analyses of an SSQ for delirium and another for 
dementia. 
Chapter 4 and 5 will evaluate what is currently being done to screen for delirium and 
cognitive impairment in older, acute care adults locally (chapter 4) and nationally within 
Scotland (chapter 5). This will establish if existing clinical guidelines are being followed.  
Chapter 6 will evaluate the performance of delirium screening tools recommended for 
routine clinical use in a cohort of 500 consecutive older patients admitted to acute care 
wards in a large, urban teaching hospital.  
Chapter 7 will discuss how the findings presented within this thesis add to the existing 
literature on screening for delirium in older, acute care in-patients as well as consider any 
clinical implications which stem from these evaluations and suggestions for future 
research.   
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Table 2 Prevalence of hypoactive delirium across all patients in different hospital 
settings (adapted from a systematic review by Peritogiannis, Bolosi, Lixouriotis & Rizos, 
2015 [11]). 
 
Setting HD prevalence 
Surgery (anesthesia & cardiac) 56-92% 
Consultation-liaison psychiatric service 6-30% 
Hip fractures 12-41% 
Intensive Care Unit 36-100% 
Internal medicine 18-65% 
Palliative care 20-53% 
Other (e.g. emergency, long-term care) 6-92% 
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Table 3 The criteria employed by the CAM to assess for delirium (adapted and 
abbreviated from Inouye et al.[16]). 
* - highlights domains used within the short CAM 
 
 
 
Delirium criteria How this is measured 
1) Acute onset * a) Evidence of acute change in mental status from baseline?  
b) (If yes) Describe change and information source. 
2) Inattention a) Patient showed difficulty focusing attention? E.g. being easily 
distracted. 
b) (If yes) Did this behaviour fluctuate during interview? I.e. increase 
and decrease in severity. 
c) (If yes) Describe behaviour. 
3) Disorganised 
thinking * 
a) Patient showed evidence of disorganised or incoherent thinking? 
E.g. rambling, illogical flow of ideas, subject switching. 
b) (If yes) Did this behaviour fluctuate during interview? I.e. increase 
and decrease in severity. 
c) (If yes) Describe behaviour. 
4) Altered level of 
consciousness * 
 
a) Rate patients level of consciousness (8 point rating scale) 
b) (If yes) Did this behaviour fluctuate during interview? I.e. increase 
and decrease in severity. 
c) (If yes) Describe behaviour. 
5) Disorientation * a) Patient disorientated during interview? E.g. disorientated to 
time/space. 
b) (If yes) Did this behaviour fluctuate during interview? I.e. increase 
and decrease in severity. 
c) (If yes) Describe behaviour. 
6) Memory 
impairment 
a) Patient showed memory problems during interview? E.g. difficulty 
remembering instruction. 
b) (If yes) Did this behaviour fluctuate during interview? I.e. increase 
and decrease in severity. 
c) (If yes) Describe behaviour. 
7) Perceptual 
disturbance 
a) Patient showed evidence of perceptual disturbance? E.g. 
hallucinations, illusions, misinterpretations. 
b) (If yes) Did this behaviour fluctuate during interview? I.e. increase 
and decrease in severity. 
c) (If yes) Describe behaviour. 
8) Psychomotor 
disturbance 
a) Increased/decreased level of motor activity during interview? E.g. 
restlessness, picking clothes, sluggishness, moving slowly. 
b) (If yes) Did this behaviour fluctuate during interview? I.e. increase 
and decrease in severity. 
c) (If yes) Describe behaviour. 
9) Altered 
sleep/wake cycle 
a) Evidence of disturbance of sleep/wake cycle. E.g. excessive day time 
sleepiness or insomnia. 
b) (If yes) Describe disturbance. 
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Table 4 Non-pharmacological interventions for the prevention of delirium and management of 
delirium risk factors adapted from a systematic review carried out by Tampi et al. (2015) 
Study Method Results 
Inouye et al. (1999) [68] Multi-component targeted risk factor 
intervention strategy vs. usual care in 
patients age 70 and over. Patients in 
the intervention group received 
standardised care for the 
management of six delirium risk 
factors; cognitive deficits, sleep 
impairment, ambulatory difficulties, 
visual impairment, hearing deficits 
and dehydration.  
Patients who received targeted 
management of risk factors were 
found to have lower incidence of 
delirium (OR=0.60), less delirious 
days in total (p=0.02) and lower 
number of episodes of delirium 
(p=0.03), compared to usual care. 
Delirium severity and recurrence rate 
were not found to differ significantly 
between the two groups.  
Marcantonio et al. (2001) [69] RCT in surgical patients age >65 
years. Comparing patients receiving 
proactive geriatric consultation to 
usual care.  
Proactive geriatric consultation was 
found to prevent one case of delirium 
in every 5.6 evaluated patients. 
Patients in the intervention group 
had a delirium incidence rate of 32% 
compared to 50% in the usual care 
group. 
 
Caplan et al. (2006) [70] Geriatric rehabilitation patients were 
randomised to either home 
rehabilitation or hospital ward 
rehabilitation.  
Patients receiving home 
rehabilitation were found to have 
lower odds of becoming delirious 
(OR=0.17).  
Millisen et al. (2005) [71] Systematic review of delirium 
prevention strategies in older 
patients.   
Prevention strategies found to reduce 
incidence, duration and severity of 
delirium in general and surgical 
patients in four indentified studies.  
Clegg et al. (2014) [72] Meta-analysis of the prevention of 
delirium in older, long-term care 
patients by discontinuing medications 
which may increase the risk of 
delirium.  
One RCT met inclusion criteria. A 
computerised system was used to 
identify medications which may 
increase the risk of delirium. This was 
then followed by pharmacist review 
of the identified medications which 
were discontinued. This was found to 
result in a reduction of the incidence 
of delirium (HR=0.42). 
Martinez et al. (2015) [73] Meta-analysis of multi-component 
interventions aiming to reduce the 
incidence of delirium. 
Analyses of data from seven 
identified studies revealed that multi-
component interventions do reduce 
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the incidence of delirium compared 
to usual care (p<0.01). No significant 
difference was found for delirium 
duration, length of hospitalisation or 
mortality rate. 
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Table 5 Summary of delirium screening tools with existing validation data based on a recent systematic review [89]. Listed alphabetically by full 
assessment test name. 
Screening tool Description Direct patient 
testing 
Informant-based  Clinician-based 
4 A’s Test (4AT) [90] 
 
4 domains; 2 direct patient-directed & 2 clinician-directed. AMT 4, 
MOTYB, level of consciousness & acute change in mental function. 
X  X 
brief Confusion 
Assessment Method 
(bCAM) [91] 
 
4 domains which rate the patients’ level of disorientation and 
altered level of consciousness as assessed by the clinician as well 
as direct-patient assessment of inattention and disorganised 
thinking. 
X  X 
Clinical Assessment of 
Confusion (CAC) [92] 
25 item tool which employs items specifically relating to 
psychomotor function. 
  X 
Confusion Assessment 
Method (CAM) [93] 
 
9 criteria tool based on DSM-III-R diagnostic criteria in delirium. X  X 
Delirium Detection Score 
(DDS) [94] 
 
5 item scale which rates the patients’ level of disorientation, 
hallucinations, agitation, anxiety and sudden (paroxysm) sweating. 
  X 
Delirium Diagnostic Tool- 
provisional (DDT-Pro) [95] 
3 domain tool. The first 2 require direct cognitive testing and 
comprise simple yes/no questions and an attention test. The 3
rd
 
item requires clinician evaluation and is based on the patient’s 
sleep-wake cycle. 
X  X 
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Delirium Observation 
Screening Scale (DOSS) [96] 
 
25-item nurse-rated scale focusing on “typical behaviour patterns” 
of delirium. 
  X 
Delirium Ratio Scale 
(DRS/DRS-R-98) [97,98] 
10 items rated by a clinician with training in psychiatry. Evaluates 
patient’s behaviours in the last 24 hours. This tool was then revised 
and released a a 2 part tool with 13 items and a further 3 
diagnostic items (DRS-R-98). 
  X 
 
Delirium Symptom Interview 
(DSI) [99] 
34 item patient interview, 26 of which are directed to the patient 
and 8 are answered by the clinician based on the behaviour of the 
patient during the interview. 
X  X 
Delirium Triage Screen (DTS) 
[91] 
Clinician-based tool which assesses the patient’s level of 
consciousness and inattention. 
  X 
Digit Span Test [100] Direct-patient testing where-by the patient is asked to repeat a 
series of numbers, typically starting at a set of 3 numbers and 
increasing by 1 extra number with each testing sequence.  
X   
Memorial Delirium 
Assessment Scale (MDAS) 
[101] 
 
10 item clinician-based assessment which assesses 3 main 
domains; arousal and level of consciousness, cognitive functioning 
and psychomotor activity. Also provides a measure of severity. 
  X 
Modified Richmond 
Agitation Sedation Scale 
(mRASS) [102] 
The clinician objectively measures the patients’ level of 
consciousness and inattention on a 10 point rating scale. 
  X 
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Nursing Delirium 
Screening Checklist (Nu-
DESC) [103] 
 
Evaluates 5 domains of patient behaviour as completed by the 
nurse; disorientation, inappropriate behaviour, inappropriate 
communication, illusions/hallucinations, psychomotor disturbance.  
  X 
Short Portable Mental 
Status Questionnaire 
(SPMSQ) [104] 
10-item tool directed at the patient asking simple questions 
relating to such things as age, place of birth, day of week and 
mother’s maiden name.  
X   
Simple Question for Easy 
Evaluation of Consciousness 
(SQUEEC) [105] 
Patient provides a narrative report relating to describing how they 
would carry out a journey, in some detail.  
X   
Single Question in 
Delirium (SQiD) [106] 
 
A single yes/no question to be asked of a close 
relative/friend/carer of the patient. The question asks; “Do you 
think X has been more confused lately?”  
 X  
Vigilance A Test [107] 
 
The patient is read a series of 60 letters and the patient is asked to 
acknowledge only when the letter A is read out. 
X   
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Chapter 2: Systematic Review 
 
2.1 Introduction 
Cognitive impairment is a significant issue in older individuals with half of those over 85 
years thought to suffer from some form of cognitive dysfunction, including MCI, 
dementia and delirium [109].  
A wide range of detailed, multi-domain assessments have been developed for the 
screening of cognitive impairment [110]. However, this is not always a feasible test 
strategy due to the time consuming nature of these tools, confusion regarding the vast 
number of screening tests available and inadequate training received by clinical staff to 
implement this form of cognitive impairment screening.  
There is substantial interest in the potential of using a staged screening process with the 
first step utilising a simple, rapid screening assessment. The shortest possible tool is a 
single question, directed at either the patient or an informant.  
The utility of a staged screening process for cognitive impairment is currently being 
investigated through the England and Wales Departments of Health Commissioning for 
Quality and Innovation (CQUIN) strategy [111]. This is a paid initiative which provides 
hospitals across England and Wales with a pathway of care with the aim of aiding the 
identification of cognitive impairment ( 
Figure 1). CQUIN provides a three step approach to cognitive impairment screening and 
detection; i) Find, ii) Assess & Investigate, iii) Refer, abbreviated as ‘FAIR’. The first step of 
this staged process implements an SSQ which is to be asked to either the patient or a 
relative/carer; “Has the person been more forgetful in the past 12 months, to the extent 
that it has significantly affected their daily life?” This question should be asked within 72 
hours of admission.  
If the answer to this SSQ given by either patient or relative is ‘yes’ then the patient 
proceeds to step 2 where diagnostic assessment should be administer. Following 
diagnostic assessment, if a negative result is found then the patient does not undergo 
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further investigation. If diagnostic assessment reveals a positive result then appropriate 
referrals should be made and results should be fed back to the general practitioner. If 
results are inconclusive then this information should be fed-back to the patients’ general 
practitioner. 
Despite this approach being adopted across a large number of hospitals there is currently 
no validation for the SSQ used within the first step of the CQUIN strategy. 
If effective, a single question screening tool for cognitive impairment has a number of 
benefits. In settings such as acute care where time is very limited, quick single question 
screening would be ideal to reduce pressure on clinicians work load. Administration of a 
single question screen requires virtually no training, unlike many of the most popular 
screens for cognitive impairment. Also, a single informant question is suitable for patients 
who are not suitable for direct cognitive testing due to severity of illness, for example.  
 
2.2 Research Question 
What is the evidence to support the use of single questions in screening for dementia 
and/or delirium? 
 
2.3 Aim 
To review and synthesise the evidence investigating the use of single question cognitive 
impairment screens for MCI, dementia and delirium.  
 
2.4 Methods 
The review methodology and reporting followed Cochrane Screening and Diagnostic Test 
Methods guidance [112]. Cochrane Library provides a resource of high quality reviews 
which aim to inform healthcare decisions and also provides guidelines on all aspects of 
the systematic review process. This review followed guidelines specifically developed for 
reviewing diagnostic test accuracy studies. Guidance included writing a protocol, 
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developing criteria for study inclusion, searching studies, assessing methodological 
quality and interpreting results.  
 
2.4.1 Search Strategy 
I performed an electronic database search over several, cross-disciplinary databases; 
MEDLINE (OvidSP), EMBASE  (OvidSP), ISI Web of Knowledge, PsychINFO (EBSCO) and 
CINAHL (EBSCO). All were searched from inception to March 2013 with no language 
restrictions. In addition to our electronic search, I contacted research groups who have 
published on cognitive screening for details of recent or in-press papers. Our chosen 
databases include conference reports and so I did not perform additional searches for 
recently presented data.   
I used a concepts approach to create strings of search terms that I combined with 
Boolean operators. Search terms were categorised under three headings; “cognitive 
impairment/dementia”, “screening” and “common cognitive assessment tools”. Where 
possible I used search terms previously validated by the Cochrane Dementia and 
Cognitive Improvement Group and supplemented these with controlled vocabulary for 
terms relevant to single questions, delirium and MCI. Suitable search strategies were 
formed and run for each database searched (Appendix A).  
To assess internal validity of our search strategy, a sample list of papers relevant to the 
study question (n=5 papers) (Appendix B) were compiled by one researcher prior to and 
independent of the creation of the search terms. I assessed whether our electronic 
search identified all the pre-specified papers and planned to review the search strategy if 
more than one target paper was not included in initial searches. 
Once the search strategies had been run in the relevant databases, two researchers 
screened all titles for relevance. Following this, abstracts of all potential titles were 
reviewed. Full papers were obtained for abstracts which met inclusion criteria.  Reference 
lists of relevant papers were scanned to identify any additional papers, repeating the 
process until no new papers were found. 
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2.4.2 Inclusion and exclusion criteria 
Our target papers were either;  
i) Studies implementing an SSQ for any form of cognitive impairment. 
ii) Studies that investigated the individual items of a multi-item cognitive assessment tool. 
Our target index test was any SSQ for cognitive impairment. These could be directed to 
the patient, informant or clinician. The single question had to include a change in 
cognition from a higher level of functioning. There was no set response format for the 
single question. 
Our reference standard included clinical diagnosis of cognitive impairment (MCI, 
dementia and delirium) using standard criteria such as the ICD [15] or the DSM [113] 
criteria. I also allowed for cognitive impairment to be defined by validated, multi-domain 
assessment tools with accepted cut-points such as the Mini-Mental State Examination 
(MMSE) score <24/30 [114], Montreal Cognitive Assessment (MoCA) score <26/30 [115] 
and Addenbrooke’s Cognitive Examination III (ACE-III) score <88/100 [116]. 
No restrictions were set on where patient cohorts were obtained (e.g. community 
samples, primary/secondary healthcare and long-term-care), age of participants, sample 
size or publication language. I only included those studies that had been published in a 
peer reviewed scientific journal.  
Any disagreement over study inclusion was resolved by discussion. 
2.4.3 Data extraction and assessments 
I transferred data from included studies to pre-specified pro-formas (Appendix C).  Two 
reviewers independently performed data extraction and inconsistencies were resolved by 
further review of source data. Data extracted consisted of: study setting, patient 
selection method, number of patients, mean age, reference standard and index test.  We 
extracted data on diagnostic test accuracy using sensitivity, specificity, positive and 
negative predictive value, Area Under the Curve (AUC) (where available). Other relevant 
statistical information was also recorded e.g. correlation coefficients, factor analysis. 
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We assessed eligible papers for risk of bias and external validity using the quality 
guidance template described in the second iteration of QUADAS-2 as recommended by 
the Cochrane Collaboration [117]. This tool asks questions relating to each study across 4 
domains; patient selection, index test, reference standard and patient flow. We 
developed a set of anchoring statements for QUADAS-2 suitable for assessment of 
dementia screening tools [118]. In diagnostic test accuracy studies, case control 
populations or populations “enriched” with additional cases can exaggerate test 
properties and so I pre-specified that we would consider studies using such a 
methodology separately from those with representative patient sampling.  
 
2.5 Results 
Once duplicates were removed, our initial combined search returned 884 papers (Figure 
2). These papers were then screened by title and abstract which left 65 papers to be 
reviewed in full text form. 11 papers were found to be eligible for inclusion in the final 
review [104, 119-128]. 1 paper was flagged as unsure for inclusion by the researches due 
to the correlation analyses reported [127] and was decided to be eligible following 
discussion between the two researchers. Our assessment of internal validity suggested 
our search strategy was adequate as all 5 pre-selected papers were returned when the 
search was run.  
There was substantial heterogeneity evident in the final 11 papers at multiple levels. 
Format and application of the index test (SSQ) varied between studies. A primary single 
question for cognitive impairment was evident in five studies and the remaining six 
studies used single item analysis derived from multi-item tools. Reference standard 
(assessment of cognitive function) also varied between studies with seven papers using 
gold-standard, diagnostic criteria [121-122, 124-128] and four papers using multiple item 
screening tools AMT [129]; the Alzheimer’s Disease-8 (AD8) [130]; the MoCA [115]; CAM 
[91]; the MMSE [114] and the Memorial Delirium Assessment Scale (MDAS) [101]). 
Heterogeneity of clinical setting was also evident. Considering studies which used a 
representative sample of the general population, clinical settings included community 
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dwelling older adults, oncology patients, stroke unit in-patients and memory clinic 
referrals.  
Heterogeneity was also identified between those papers that used a primary SSQ on 
three levels; who the question was administered to, the type of cognitive impairment the 
question was attempting to identify and the method of response. Questions were given 
to relatives / informal carers in two studies [106, 122], patients in two studies [119, 123] 
and health care workers in one study [120]. Two studies used a single question to screen 
for dementia [119, 123]. Two studies used a single question to screen for cognitive 
impairment (dementia/MCI/delirium) [120, 122]. One SSQ screened for delirium [106]. 
One study used a Likert scale to quantify response [106]; the other four studies used a 
dichotomised yes or no response [119, 120, 106, 123] (Table 6). 
Given the broad range of heterogeneity I believed it more appropriate to present our 
findings as a narrative review rather than meta-analysis.  
The QUADAS-2 [117] tool was employed to assess each of the 11 papers for risk of bias 
and applicability concerns. The domains assessed for each paper were patient selection, 
index test, reference standard and flow & timing. This revealed that four [106, 119-121] 
of the 11 papers had low risk on all domains. The remaining seven studies had unclear or 
high risk in at least one domain [122-128].  Risk of bias was most common in the patient 
section procedures employed by the studies, with six papers being assessed as high or 
uncertain risk [122-126, 128]. Table 7 provides an illustration by individual paper of the 
risk of bias for each assessment domain. Figure 3 collates this analysis to show the 
proportion of each level of risk of bias (low, high and unclear) present within each domain. 
Considering specifically the studies which used a component analysis of multi-item 
instruments [121, 124-128] there was some consistency in the types of single items 
favoured. Questions using the wording “decline in memory function” and “change in 
ability to think/ reason” performed well, as seen in the Community Screening Interview 
for Dementia (CSI-D) or Clinical Dementia Rating (CDR) [121, 124, 126]. 
Four studies recruited representative patient samples with the other seven papers having 
“enriched” samples where-by either preferential recruitment of patients with cognitive 
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impairment (n=4) [122, 125-127] or case-control methodology (n=3) [123, 124, 128] was 
used.  Also, source data from the Informant Questionnaire for Cognitive Decline in the 
Elderly (IQCODE) [127-128] revealed that “general change in intelligence” was the 
favoured item. As the included papers presented their results using differing and non-
interchangeable measures (Receiver Operating Characteristics (ROC); correlation 
coefficients; conventional significance testing and classical test accuracy metrics) I was 
unable to perform direct comparisons. Table 8 further illustrates the best performing 
single items derived from multi-question screening tools, separated by individual paper.  
Evidence tables of the 11 studies included within this review are presented in Table 9 and 
Table 10. The presented evidence is tabulated separately by sampling method with Table 
9 illustrating studies which used a consecutive/representative patient sample and Table 
10 showing studies which used case control/stratified patient samples. 
The studies which used a representative sampling frame revealed that an informant-
based screening question for delirium had both good sensitivity and specificity in an 
oncology setting [106] but sensitivity was less good in a stroke setting [120]; also, an SSQ 
for dementia given directly to the patient correlated weakly but significantly with 
informant AD8 score (Spearman r=0.25, p<0.001) [119]. There were no papers that 
presented test accuracy data on a single question for clinical diagnosis of dementia.  For 
those papers using a case control or enriched sampling approach, test properties were 
generally good. Where classical test accuracy data were available, sensitivity ranged from 
65% to 96% and specificity 45% to 99%.  
 
2.6 Discussion 
This systematic review focused on studies which compared single question screens with 
either a clinical diagnosis of cognitive impairment or validated assessment for cognitive 
impairment. A modest number of studies were available; of these only five included a 
specific SSQ and of these only three avoided a case-control approach. Based on our 
review I would have to conclude that while certain single questions show promise, robust 
evidence supporting a single question approach to cognitive screening is currently lacking. 
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The heterogeneity in application of a single question screening strategy was striking. The 
questions employed varied in wording, exploring general impressions of memory, 
confusion and cognitive function, with no clear advantage to any particular form of words. 
Questions were posed to carers, healthcare staff and the patients themselves and were 
used to screen for a spectrum of cognitive diagnoses across a variety of healthcare 
settings. The data available do not allow us to make any recommendations on how to 
best use the single question format.  
Despite the heterogeneity I can still make some broad conclusions from the available 
data. Although none of the studies directly compared different sources of information for 
single questions such as carer versus patient versus health care worker, indirect 
comparisons suggested that administering screening questions to a close friend or 
relative performed more accurately [122] than directing question to the patient [123] or 
to ward-based multidisciplinary team [120].   
While the primary interest of this review was studies of single questions, I recognise the 
potential of generating useful single questions from component analysis of multi-item 
cognitive assessments and included studies that employed this approach. Across six 
studies general questions on cognition, for example referring to a decline in memory or 
intellectual function, seem to perform as well as or better than questions on specific 
abilities such as being “unable to handle financial transactions”. If long multi-domain 
assessments can be reduced to single questions without substantial loss of diagnostic 
accuracy then this should be explored as it will allow for more efficient testing and reduce 
patient burden.  
The majority of included studies had issues relating to internal or external validity. 
Sampling was the primary driver to the risk of bias with only four studies recruiting a 
representative sample. Non-representative sampling included using enriched sampling 
methods [122, 125-127] to increase the proportion of subjects with cognitive problems 
compared to the general population and using case-control methodology [123-124, 128]. 
Both of these sampling methods are likely to favourably exaggerate the performance of 
any tool and the test accuracy data from these studies must be treated with caution. At 
best I would consider these studies as providing useful preliminary data on the potential 
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utility of different screening methods that would require confirmation in “real world” 
consecutive clinical samples.  
Although our systematic review can neither support nor refute the accuracy of a single 
question; as a low cost, low effort tool for large-scale initial assessment the single 
question approach remains attractive. SSQ’s have been useful for other mental health 
disorders such as the validated single item from the Yale-Brown obsessive compulsive 
scale [131] as a depression screen [132] and the Distress Thermometer that is used to 
screen patients with cancer for stress [133]. The NHS in England and Wales have 
proposed large scale dementia screening that uses a single question as the first step in 
the assessment pathway. The screening method proposed in the NHS CQUIN is claimed to 
be based on a similar existing screening method for detecting delirium, the Single 
Question in Delirium (SQiD), which asks the patients friends or family; “Do you think 
[name of patient] has been more confused lately?” [106]. While the results of this 
systematic review suggest there may be some value to a single question screening 
approach for cognitive impairment (delirium and dementia), the available data are weak 
and neither of these questions have been fully validated. I would encourage health care 
professionals to embed test accuracy studies within the usual standard practice of the 
CQUIN to help evaluate this approach and inform future policy and guidance. 
This systematic review was strengthened by the use of QUADAS-2 [117] quality 
assessment software on all included studies. This approach allowed us to identify clearly 
that the main risk of bias lay with patient selection, which prompted us to separate 
studies by recruitment type. This then allowed us to make more accurate conclusions 
based on the results of representative sample studies while applying more caution to 
conclusions drawn from results of stratified or case control studies. This review was also 
strengthened by the use of two independent researchers evaluating the 
inclusion/exclusion of all identified studies.  
A possible limitation of this systematic review is that it has not addressed the literature 
on patient’s subjective memory complaints, which could also be considered as a single 
patient-response item.  This may be a literature area of value for future systematic review. 
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2.7 Conclusion 
In conclusion, our data suggest that a single informant screening question assessing a 
general cognitive domain such as memory decline may be a promising initial screening 
method for dementia.  However, study quality and heterogeneity preclude any more 
definitive statements. Further research studies are required including representative 
samples of older adults to test accuracy data across a variety of settings. Ongoing work to 
improve and standardise dementia test accuracy studies such as the Reporting Standards 
in Dementia and Cognitive Impairment (STARDdem) initiative [134] may raise the 
standards and utility of future single question studies. Without further high quality test 
accuracy studies, I would not recommend large scale screening using a single item 
approach. However, I would recommend the implementation of SSQ’s for cognitive 
impairment in to research studies assessing other screening tools, to gain a clearer idea 
of the utility of SSQ’s for delirium and/or dementia.  
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Figure 1 England and Wales Departments of Health Commissioning for Quality and Innovation (CQUIN) strategy. 
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Figure 2 Flow chart illustrating the search process to identify suitable studies for 
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Table 6 Wording and application of SSQ’s for cognitive impairment. 
 
 
 
 
 
 
 
Author SSQ Respondent Cognitive 
Impairment 
Ayalon [122] How would you rate 
your friend or 
relatives memory at 
the present time? (5 
point scale) 
Relative / informal 
carer 
MCI 
Dementia 
Sands et al. [106] Do you think 
[patient’s name] has 
been more confused 
lately? (yes/no) 
Relative / informal 
carer 
Delirium 
Chong et al. [123] Participants asked 
about their 
experience of 
progressive 
forgetfulness 
(yes/no) 
Patient  Dementia 
Galvin et al. [119] Asked whether they 
had a problem with 
memory (yes/no) 
Patient Dementia 
Lees et al. [120] Does this patient 
have cognitive 
issues? (yes/no) 
Multidisciplinary 
stroke team 
All cause cognitive 
impairment 
Delirium 
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Table 7 QUADAS table addressing risk of bias and applicability concerns. 
 
Study RISK OF BIAS APPLICABILITY CONCERNS 
PATIENT 
SELECTION 
INDEX TEST REFERENCE 
STANDARD 
FLOW 
AND 
TIMING 
PATIENT 
SELECTION 
 
INDEX TEST REFERENCE 
STANDARD 
Ayalon  ☺ ☺   ? ☺ ☺ ☺ 
Chong  ☺    ? ☺ ☺ ☺ 
Douglas    ?   ?   ? ☺ ☺ ☺ 
Erkinjuntti    ? ☺ ☺ ☺ ☺ ☺ 
Galvin ☺ ☺ ☺ ☺ ☺ ☺ ☺ 
Hall  ☺   ?  ☺ ☺ ☺ 
Lees ☺ ☺ ☺ ☺ ☺ ☺ ☺ 
Morales   ? ☺ ☺ ☺ ☺ ☺ ☺ 
Perroco  ☺   ?   ? ☺ ☺ ☺ 
Prince ☺   ☺ ☺ ☺          ☺ ☺ ☺ 
Sands ☺ ☺ ☺ ☺ ☺ ☺ ☺ 
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Figure 3 Illustrative summary of risk of bias and applicability concerns of studies 
included in this review using the QUADAS-2 tool. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient Selection
Index Test
Reference Standard
Flow and Timing
0% 25% 50% 75% 100% 0% 25% 50% 75% 100%
Risk of Bias Applicability Concerns
High Unclear Low
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Table 8 Best performing items from component analysis of multi-item cognitive 
assessment tools. 
 
CDR =community dementia rating; CSI-D =Community Screening Interview for Dementia ; IQCODE = 
Informant Questionnaire for Cognitive Decline in the Elderly 
 
Author Index 
Test 
Useful items 
Prince et al. [121] CSI-D • ‘decline in memory functioning’  
•  ‘change in ability to think/reason’ 
• ‘forgetting where have put things’ 
• ‘forgetting current location’ 
• ‘difficulty dressing’ 
• ‘forgetting day before’ 
Hall et al. [126] CSI-D • ‘Decline in memory function’              
• ‘Change in ability to think/reason’ 
Sensitivity  
Douglas et al. [124] CDR 
 
• ‘Problems with memory or thinking’ 
Erkinjuntti et al. [125] Blessed 
dementia 
scale 
• ‘Inability to perform household tasks’  
• ‘Inability to remember short lists of 
items’ 
 
Morales et al. [127] IQCODE 
 
• ‘General change in intelligence’                              
Perroco et al. [128] IQCODE • ‘General change in intelligence’  
• ‘General change in memory’ 
• ‘General change in ability to learn new 
things’ 
Table 9 Data from included studies, representative cohorts of consecutive/semi
 
Study & 
Setting 
Patient selection          
Galvin et al. 
(2007) 
USA [119] 
Community based, 
consecutive sample 
 
325 
CDR ≥ 1 = 23%
Lees et al. 
(2013) 
UK [120] 
Stroke patient, consecutive 
sample 
111 
MoCA <
Prince et al. 
(2011) 
Latin 
America, 
India and 
China [121] 
Population based sample 15,022
 
Sands et al. 
(2010) 
Australia 
[106] 
Oncology inpatients 
consecutively admitted on 
nominated days 
19 
Psychiatric 
interview 
identified 5 cases 
delirium (26%)
 
 
-consecutive unselected patients.
N Mean age 
(years) 
Reference Tool Screening Tool 
 
76.8 (± 8.9) AD8 Account of memory 
problems 
(patient) 
 26 = 86% 
74.0  
(IQR 64 – 
85) 
MoCA  
CAM 
Single screening 
question (asked of 
professionals at 
stroke 
multidisciplinary 
team meeting) 
 No 
information 
on age  
 
DSM-IV 
CDR 
CSI-D (informant) 
 
53.2 
(Range 30-79) 
Psychiatrist interview 
CAM 
MMSE 
MDAS 
SQiD (informant) 
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       Results 
• SSQ correlated to 
informant AD8 
=0.25, p<0.001; 
Patient AD8 =0.49, 
p<0.001 
• SSQ for any 
cognitive 
impairment- 
sensitivity 26%, 
specificity 100% 
• SSQ delirium- 
sensitivity 58% 
specificity 85% 
• Extracted 6 best 
performing informant 
items from CSI-D; 
• See table 3  
• SQiD for delirium 
• Sensitivity- 80%  
Specificity- 71% 
NPV- 80% 
PPV- 91% 
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Table 10 Data from included studies, Case–control and stratified or enriched sample studies 
Enriched sampling refers to studies which recruit larger numbers of cognitively impaired individuals than is representative to that sample, thus threatening validity of results as this form of 
sampling is likely to exaggerate performance of any tool used 
Study & 
Setting 
Patient selection N Mean age 
(years) 
Reference Tool Screening Tool Results 
Ayalon 
(2011)  
USA [122] 
Stratified sample from 
population-based study 
256 controls 
185 MCI 
206 dementia 
77.4 controls 
80.5 MCI 
83.7 
dementia 
Psychiatrist/Neur
ologist diagnosis 
DSM-III-R & DSM-
IV 
Single-Item 
Question 
(Informant) 
• Dementia; 
Sensitivity- 95.7% 
Specificity- 75.3% 
• MCI 
Sensitivity- 81.1% 
Specificity- 75.3% 
 
Chong et al. 
(2006) 
China [123] 
Community-based study; case 
control sample (progressive 
forgetfulness, low AMT & 
control group) 
128 cognitive 
impairment 
49 controls 
66.8 AMT Single question 
test on 
progressive 
forgetfulness 
(patient) 
• Patient SSQ versus AMT 
• Sensitivity- 95.7%  
Specificity- 45.1% 
Douglas et al.  
(2011) USA 
[124] 
 
Memory clinic; 
Case control study 
 
180 controls 
104 MCI 
309 dementia 
65 controls 
73 MCI 
72 dementia 
Neurologist 
diagnosis 
CDR 
(informant) 
• Identified 5 best predictor 
items from CDR of a clinical 
diagnosis of chronic 
cognitive impairment; 
• See table 3 
Erkinjuntti et 
al. (1988) 
Finland [125] 
 
Community-based; 
Stratified random sample 
 
123 controls 
105 dementia 
66.0 controls 
68.6 
dementia 
DSM-III diagnosis Blessed dementia 
scale 
(informant) 
• Inability to perform 
household tasks – sensitivity 
64.8% specificity 99.2% 
• Inability to remember short 
lists of items – sensitivity 
68.9% specificity 97.6% 
Hall et al. 
(1996) 
USA & 
Nigeria [126] 
Stratified enriched sample 
from large community 
samples (USA 2212 Nigeria 
2494).  Community screen of 
CSI-D stratified based on 
USA 
Controls 286 
Dementia 65  
Nigeria 
Controls 395 
74.0 + 7.0 
(USA) 
72.3 + 7.5 
(Nigeria) 
Age only given for 
DSM-III 
ICD-10 
CDR   
CSI-D  
(informant) 
USA data 
• Remembering is a problem –      
sensitivity 81.6% specificity 
45.2% 
• Decline in mental 
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performance with 100% poor 
performers included (N= 341), 
50% intermediate performers 
(N=181) and 5% good 
performers (N=190)  
 
Dementia 28  entire community 
samples 
functioning-  
Sensitivity 77.6% Specificity 
63.8% 
• Change in ability to think & 
reason- Sensitivity 76.0% 
Specificity 61.4% 
Morales et 
al. (1995) 
Spain [127] 
Community based sample; 
stratified by age and sex. 
Restricted sampling 
augmented those with cog 
problems 
61 controls 
7 dementia 
73.1 DSM-III 
neurologist 
diagnosis 
Spanish-IQCODE 
(informant) 
• Correlations between 
individual items and total S-
IQCODE scores; 
• ‘In general, intelligence 
changed’ R=0.86 
• ‘In general, memory for 
recent happenings’ R=0.69 
• ‘In general, change in ability 
to learn new things’ R=0.64 
Perroco et al. 
(2009) 
Brazil [128] 
Memory clinic; 
Cross-sectional case control 
study 
 
58 controls 
34 dementia 
 
69.2 controls 
73.7 
dementia 
ICD-10  
SRQ-20  
AMTS 
IQCODE  
traditional and 
revised short 
form version 
(informant) 
• ROC curve for each 
IQCODE item 
• Learning new things 
(AUC=0.92), Memory for 
recent happenings 
(AUC=0.86), Intelligence 
changed (AUC=0.82). 
 
AD8= Alzheimer’s Disease 8; AMT= Abbreviated Mental Test; CAM= Confusion Assessment Method; CDR =community dementia rating ; CSI-D =Community Screening 
Interview for Dementia ; DSM= Diagnostic and Statistical Manual of Mental Disorders; IQCODE = Informant Questionnaire for Cognitive Decline in the Elderly; MCI= Mild 
cognitive impairment; MDAS= Memorial Dementia Assessment Scale ; MoCA= The Montreal Cognitive Assessment; SSQ= Single screening question; SQiD= Single Question 
in Dementia 
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Chapter 3: Secondary data analysis of single 
screening questions used in acute care. 
 
3.1 Overview 
‘Cognitive impairment’ is a term covering a range of disorders from those with chronic 
cognitive impairment characterised by a gradual, progressive course encompassing the 
varying forms of dementia to disorders with rapid, acute onset such as delirium and sub-
syndromal delirium.  
Cognitive impairment is common in acute care with 40-70% of elderly patients in UK 
hospitals thought to have dementia [135]. However, less than half of these patients have 
an existing diagnosis [136]. Patient’s admitted to the acute care hospital setting present 
an assessment opportunity for assessment of cognitive impairment during their hospital 
stay. 
Delirium is also common within the acute care setting. A point-prevalence study of 280 
patients in acute care found prevalence of delirium to be 20%; or when considering only 
patients age > 80 years, prevalence was found to be 35% [84]. Half of patients with 
delirium in this study were found to have a pre-existing dementia. Furthermore, 
systematic review revealed a point prevalence of 15-30% among elderly patients at 
admission and an incidence rate of up to 56% during hospitalisation [137].  
There is currently no one agreed strategy when screening for cognitive impairment within 
the hospital setting perhaps with a lack of validation and training for delirium and 
dementia screening tools. Usually a direct patient testing method is used when screening 
for cognitive impairment using brief tests of components of cognition such as memory, 
attention and visuospatial abilities. Arguably, this form of screening may not capture all 
the information of interest, as it only looks at one moment in time rather than change 
from a potentially higher, baseline level of cognitive function [138]. Informant-based 
assessment may gain preference as it is less vulnerable to cultural and educational bias. 
To investigate if the patient presents with a neuropsychological change over time, 
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whether chronic or acute, screening tests have been developed which aim questions at 
an informant such as a relative or primary carer.  
Informant-based screening tools exist for dementia with the most widely used and 
validated being the 26-item IQCODE [139], which also exists as a revised, 16-item 
screening tool [140]. Very brief, SSQ’s have been developed for both dementia [119, 121-
123] and delirium [106, 120], although lack validation and consensus.  
A number of SSQ’s for cognitive impairment currently exist although none that are 
validated within the elderly, acute care population and show inconsistency on a number 
of levels; question wording, respondent type (patient/carer/informant), response type 
(dichotomised/Likert scale) [141]. 
 
3.2 Research Question 
How do SSQ’s for delirium and dementia perform within the acute care hospital setting? 
 
3.3 Aim 
I aimed to assess the performance of two SSQ’s, one for delirium and one for dementia, 
in hospitalised, elderly individuals as part of a secondary analysis of a local, previously 
collected data set. 
 
3.4 Methods 
3.4.1 Participants 
This was an observational pilot study of patients > 65 years old of which my role in the 
investigation was solely the analysis of the available data. The original purpose of this 
data collection was to establish the proportion of older medical and geriatric in-patients 
with a diagnosis of dementia as well as to examine any documented contact with local 
psychiatric services. Patients were selected from either an acute medical unit (October-
December 2004) or Geriatric Assessment Unit (GAU) (February-March 2005) of an urban 
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teaching hospital. The acute medical unit admits patients of all ages in need of 
emergency hospital admission. The GAU admits patients age > 65 years old and 
preferentially selects those with complex co-morbidities; frailty; physical and/or cognitive 
decline. Patients were selected using random number tables which were linked to 
alphabetical order of patient name. A maximum of 7 patients were recruited per 24 hours.  
Patient exclusions were; the verbal component of the Glasgow Coma Scale rated as none 
or sounds only, moderate-severe dysphasia (grossly impaired comprehension, 
unintelligible speech, or major difficulties in expression), non-English speaking, learning 
disability, major deafness or blind, or readmission of patient previously included in the 
study. 
The patient’s capacity to provide consent was indicated by an independent doctor. In 
cases where the Doctor concluded the patient did not have capacity to provide own 
consent for participation, written informed consent was provided by their next of kin. The 
informant was provided with an information sheet which provided information on study 
objectives and the nature of patient participation with the opportunity to ask questions, 
prior to providing consent.  
Reference standards for dementia and delirium were performed within 36 hours of the 
patient’s admission. These included the MMSE for dementia and the CAM for delirium. 
The assessments were performed by a single trained observer, a senior medical student, 
who received formal one-to-one training in bedside cognitive assessment from an 
experienced consultant geriatrician. 
Information was also obtained from patient medical records following cognitive 
assessment. This included demographic details such as age, sex and date of birth, current 
living arrangements and next of kin information. I described functional ability using an 
IADL scale [142]. 
Where possible, the next of kin was provided with a study pack which contained an 
introductory letter, information sheet, two consent forms, IQCODE, SSQ’s for dementia 
and delirium as well as an envelope to return the consent form, IQCODE and two SSQ’s.  
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The preferred method of study pack administration to next of kin was face-to-face with 
verbal instruction from the researcher. If this was not possible, the study pack was posted 
to the home address. In cases where the next of kin was not available to complete the 
study, any relative or carer who had known the patient for the last 5 years was eligible to 
take part in the study.  
The study was approved by the Scotland A Multi-centre Research Ethics Committee. 
 
3.4.2 Reference standards  
The CAM [93] is a commonly used measure of delirium in hospitalised patients. The CAM 
consists of 9 operationalised criteria based on the DSM-IIIR. Observations made during 
direct cognitive testing as well as information obtained from nurse interview regarding 
fluctuating course and sleep-wake cycle are used to evaluate four components of patient 
cognition; acute onset and 1) fluctuating course, 2) inattention, 3) disorganised thinking 
and 4) altered level of consciousness. For delirium to be diagnosed by the CAM, criteria 1) 
and 2) must be present as well as either 3) or 4). 
The 16 item IQCODE [143] is an informant-based questionnaire which asks relatives to 
consider changes in the patient’s abilities at certain activities within the last 10 years. 
Such items include “remembering where things are usually kept” and “learning new 
things”. Relative responses are given on a 5-point Likert scale ranging from “Much 
improved” to “Much worse. Average rating across all items is then calculated with a cut 
off of >3.38 accepted as indicative of possible dementia in this study. 
The MMSE [114] is a multiple component screening tool which aims to measure 6 
cognitive domains; orientation, registration, attention & calculation, recall, language and 
copying ability. The test is administered directly to the patient, usually by a member of 
the medical team. The test is scored out of a total of 30 with a score of <24 generally 
accepted as indication of possible cognitive impairment. 
49 
 
3.4.3 Index tests 
Two single questions were developed to specifically screen for dementia and delirium 
separately. These were based on the question format of the IQCODE as an existing, 
validated informant-based cognitive assessment method. 
The SSQ-dementia was; 
“How has your relative/friend’s memory changed over the past 5 years (up to just before 
their current illness)?” 
The SSQ-delirium was; 
“How has your relative/friend’s memory changed with his/her current illness?” 
Response format imitated that of the IQCODE using a 5-point Likert scale used for each 
question; 
Much Improved/A Bit Improved/Hasn’t Changed Much/A Bit Worse/Much Worse 
 
3.4.4 Statistical analysis 
Data were analysed using Statistical Package for the Social Sciences (SPSS) version 19. 
Clinical and demographic information was examined using descriptive statistics. I 
compared subjects with and without an informant response. 
For analysis of SSQ data, I used three categories: “much worse”; “bit worse” and “no 
decline” (which was a combination of “much better”, “bit better” and no change scores). 
To allow test accuracy analysis, SSQ responses were further dichotomised as suspected 
cognitive impairment (“bit worse” and “much worse” responses) and no cognitive 
impairment (“much better”, “bit better” and “no change” responses). 
I used ROC analyses to compare the index test of SSQ-delirium against the reference 
standard CAM and also the MMSE. I compared SSQ-dementia against the reference 
standard of IQCODE. I used usual diagnostic thresholds for IQCODE (mean score <3.38) 
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and for MMSE (total score <24). 
I described diagnostic metrics of sensitivity; specificity; positive and negative predictive 
value and corresponding 95% confidence intervals (95%CI). 
I described differences in scores on ordinal reference standard tests (IQCODE and MMSE) 
for the three SSQ categories across both SSQ’s. Patient’s scores on the MMSE and 
IQCODE were analysed for statistical significance between the three SSQ outcomes using 
Kruskal-Wallis H Test analyses. Between group analyses were then carried out to 
determine where the statistical difference existed using Mann Whitney U post hoc 
analysis with Bonferroni correction. 
 
3.5 Results 
A total of 161 patients were recruited; 80 from the acute care unit and 81 from the GAU 
across a 3 month period (October-December 2004). Patient’s characteristics are 
summarised in Table 11, with separate analyses for those with and without SSQ 
responses from an informant. SSQ’s were completed for 71/161 (44.1%) of patients. 
Characteristics of respondents only differed significantly in terms of age (p=0.049). There 
was no statistical difference in proportions living alone / with family between those with 
and without an informant response. IADL assessment revealed that the patient cohort 
was relatively independent. 
Considering the 70 patients who had completed SSQ delirium and dementia data, 26 
(37.1%) had a positive screen for both the dementia and delirium question, 25 (35.7%) 
had a negative screen on both questions, 10 (14.3%) had a positive screen for dementia 
only and 9 (12.9%) had a positive screen for delirium only 
Kruskal-Wallis H Test analysis revealed a statistically significant difference in MMSE 
scores between the different SSQ-delirium outcomes (H(2) = 21.4 , p < 0.001). MMSE 
scores between the different SSQ-dementia outcomes were found to be statistically 
significant (H(2) = 16.8, p < 0.001). See 
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Table 12 for further detail on average scores across response type.  
Analyses also revealed a statistically significant difference in IQCODE scores between the 
three different SSQ-delirium outcomes; (H(2) = 27.3, p < 0.001), mean scores of 3.4 for 
those identified as “no change or better”, 3.9 for those identified as “a bit worse” and 4.6 
for patients identified as “much worse”. 
A statistically significant difference in IQCODE scores was also found between the 
different SSQ-dementia outcomes; (H(2) = 41.2, p < 0.001), mean scores of 3.2 for those 
identified as “no change or better”, 3.9 for patients identified as “a bit worse” and 4.7 for 
patients identified as “much worse”. 
ROC analyses revealed the sensitivity and specificity values of the SSQ-dementia and SSQ-
delirium, when comparing the SSQ’s to a routinely used screening test (IQCODE with a 
cut-score of <3.38 and CAM positive diagnosis respectively). The SSQ-dementia was 
found have an AUC of 0.882 and SSQ-delirium had an AUC of 0.665 (Figure 4). The SSQ-
dementia had a sensitivity of 83.3% (35/42) and specificity of 93.1% (27/29). The 
sensitivity of the SSQ-delirium was 76.9% (10/13) and specificity was 56.1% (32/57) 
(Figure 5). Sensitivity, specificity, positive predictive values and negative predictive values 
are reported in Table 13. 
 
3.6 Discussion 
The most prominent finding from this analysis was the high sensitivity and specificity of 
the SSQ for dementia. This one-item screen performed at a similar level to the routinely 
used 16-item IQCODE. However, while the SSQ for delirium showed a similar sensitivity, it 
had low specificity. Almost half of individuals with normal cognitive functioning, as 
classified by CAM diagnosis, were identified by the SSQ having suspected delirium. 
While the SSQ-delirium appeared not to perform well as a first step tool in delirium 
detection, this may be better explained by methodological issues with difficulties in 
screening for delirium, in general. A defining feature of delirium is fluctuation in presence 
of symptoms, and as such it is very difficult to have exact concurrence between a 
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screening tool for delirium and the reference standard; in this study the SSQ-delirium and 
CAM, respectively. Thus, it is possible that delirium can be present at one testing point 
but not the other. Interpretation of the performance of the SSQ-delirium in this study is 
limited as data on the time lag between the SSQ-delirium and CAM was not collected. It 
would also be of interest for future studies to test the SSQ-delirium blinded from CAM 
diagnosis. 
Undiagnosed dementia may account for the high number of false positive results 
identified by the SSQ-delirium. The majority of patients identified as positive by the SSQ-
delirium also had a positive result on the SSQ-dementia. It is possible that an informant 
based question is not suitable to accurately differentiate those at high risk of having 
delirium from those at high risk of having dementia. 
Direct cognitive testing of patients is the most commonly used screening method for 
cognitive impairment [144]. However, informant testing shows promise in improving 
detection of at-risk individuals. It has been demonstrated that an informant 
questionnaire shows the same performance as direct cognitive testing, despite the fact 
that these different screening tools measure different patient attributes [145]. A major 
advantage of informant based assessments is that they do not suffer the same problems 
as cognitive testing and is not affected by education level or susceptible to ceiling effects 
[124]. Single question screening for cognitive impairment is a hot topic at the moment 
and there is a paid incentive being rolled out across hospitals in England in an attempt to 
improve diagnosis of patients with cognitive impairment known as the CQUIN framework 
[111]. Of particular interest to this study is the first stage, ‘Find’ whereby the patient or 
informant is asked the question, ‘Has the patient been more forgetful in the last 12 
months to the extent that it has significantly affected their daily life?’ This suggests that 
single question methods of screening for cognitive impairment are beginning to be used 
on a large scale despite not being fully validated. 
The advantage of using an informant-based screening tool for delirium is less clear than 
for dementia. Due to the fluctuating nature of delirium, it can easily be missed and the 
need for a relative to be present to provide information introduces further timing 
challenges as access to informants is only possible at discrete selected times. However, 
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evidence suggests that delirium is most prevalent in older patients when they are at their 
most sick, usually soon after admission or in those patients who have prolonged 
hospitalisation. Thus, those may be particularly important times to use the SSQ-delirium. 
It is clear from the literature that some form of delirium screening is needed rather than 
subjective clinical judgement which has been shown to perform poorly at detecting 
prevalent delirium [74]. This supports the need for a more structured approach to be 
implemented as a brief first step to identify those with suspected delirium who would 
then be assessed using diagnostic tools such as the CAM. 
Routine screening for cognitive impairment is necessary in older hospitalised patients and 
effective screening is beneficial to clinical staff as well as the outcomes of the patients. 
This task is made more difficult by the lack of uniformity regarding the various screening 
tools available [146]. 
Caution must be taken when interpreting these results as the reference standards were 
screening tests rather than a formal clinical diagnosis. The recruitment and consent 
strategy could have led to biases within this study; those at higher risk of cognitive 
impairment may have had more visits from family and hence more likely to return the 
informant questionnaire, especially in cases where the patient was unable to provide 
consent and hence a relative or carer had to provide consent. As this study obtained 
single question informant report in less than half of patients this raises issues of feasibility 
as there is strong potential for many individuals with suspected cognitive impairment not 
being assessed. From this data set, it is unclear whether such low response rates were 
due to patients not having a suitable relative or carer available to answer the SSQ’s or 
whether it was due to a lack of appropriate measures taken by the researcher to insure 
return of informant responses. 
Presenting informants with the IQCODE prior to answering the SSQ’s may also have 
influenced the results, possibly enhancing how well the SSQ’s appeared to perform. 
However, within these limitations I believe these results still provide useful information 
on how simple responses from informants may perform. This pilot study was 
strengthened by broad inclusion criteria thus providing a sample relatively representative 
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of older adult acute care admissions. The SSQ’s were based on the format of a validated 
informant questionnaire, the IQCODE. 
These preliminary findings show promise for use of a single question screening tool as the 
first step in the detection of cognitive impairment and prompt more thorough 
investigation. As yet there is no one cognitive screening tool that has achieved 
widespread consensus, thus the comparisons made to the IQCODE and MMSE only 
provide evidence for the value of carrying out a more in-depth study. Future research 
should compare the single question screen to a gold standard clinical evaluation as well 
as against other, more detailed screening tools of dementia and delirium to determine 
more reliable diagnostic test accuracy figures. The use of an informant-based SSQ may be 
particularly useful in combination with a direct cognitive testing method in helping to 
distinguish patients who fall within the middle, grey area of scores on cognitive test 
based screening tools. Furthermore, it is apparent that there is need for investigation to 
determine how to get higher uptake of relatives/carers to provide informant report. 
 
3.7 Conclusions 
This analysis has provided evidence that a single-item informant based screen may 
perform in a comparable way to much longer screens for dementia by effectively 
differentiating those with suspected cognitive impairment from normally functioning 
patients. Further validation is warranted. However, if a screening tool as straightforward 
as asking a single question, which has low time cost and requires little to no training to 
administer, can perform as well as more complex screens such as the IQCODE, then it 
would seem intuitive that this is a preferable option. However, results showed that a 
single question screening tool may not have the same potential when identifying 
individuals with suspected delirium. 
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Table 11 Summary of characteristics of all patients with specification of respondents 
and non-respondents to the single screening questions. 
 
 All patients Patients with 
informant 
Patients with no 
informant 
(n = 161) (n = 70) (n = 91) 
Mean age (years) 79.6 80.9 * 78.6 * 
(range = 65–
97) 
(range = 67–97) (range = 65–94) 
Male n (%) 62 (38.5%) 27 (38.5%) 35 (38.5%) 
Living arrangements n (%): 
Alone 80 (49.7) 32 (45.7) 48 (52.7) 
With spouse/other 
family 
66 (41.0) 31 (41.2) 35 (38.5) 
Sheltered 
accommodation 
8 (5) 4 (4) 4 (4) 
Nursing/residential care 4 (2.5) 1 (1.4) 3 (3.3) 
Cognitive and functional assessments 
MMSE mean (SD) 18.9 (7.7) 18.5 (8.1) 19.2 (7.5) 
MMSE <24 n (%) 107 (66.4%) 45 (64.3%) 62 (68.1%) 
CAM positive n (%) 27 (16.8%) 13 (18.6%) 14 (15.4%) 
IADL mean score (SD) 8.7 (4.3) 9.1 (4.2) 8.4 (4.4) 
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Table 12 IQCODE and MMSE scores (means and S.D.) across SSQ delirium and dementia 
responses. 
 
SSQ response No change or better Bit worse Much worse 
IQCODE Delirium SSQ 3.4 3.9** 4.6** 
(SD = 0.6, N = 35) (SD = 0.6, N = 25) (SD = 0.5, N = 10) 
Dementia SSQ 3.2 3.9** 4.7** 
(SD = 0.4 N = 34) (SD = 0.6 N = 27) (SD = 0.4, N = 10) 
MMSE Delirium SSQ 22.9 15.0** 12.0** 
(SD = 5.6, N = 35) (SD = 8.6, N = 25) (SD = 5.8, N = 10) 
Dementia SSQ 22.0 17.1* 10.1** 
(SD = 6.3, N = 34) (SD = 7.9, N = 27) (SD = 6.6, N = 10) 
Notes: Mann Whitney U post hoc analysis with Bonferroni correction. 
* = p < 0.01, ** = p < 0.001, compared to ‘nochange or better’. 
Abbreviations: MMSE = Mini-mental state examination; IQCODE = Informant 
questionnaire on cognitive decline in the elderly; IADL = Instrumental activities of daily 
living. 
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Table 13 Analysis of diagnostic accuracy. 
 
 Single Question for 
Delirium 
CAM + ve 
Single Question for Dementia 
IQCODE <3.38 
Area Under Curve (95%CI) 0.67 (0.51-0.82) 0.88 (0.80-0.97) 
Sensitivity of Single Question 
% (95% CI) 
10/13 
76.9 (46.2-95.0) 
35/42 
83.3 (68.6-93.0) 
Specificity of Single Question 
% (95% CI) 
32/57 
56.1 (42.4-69.3) 
27/29 
93.1 (77.2-99.2) 
Positive Predictive Value of Single 
Question 
% (95% CI) 
10/32 
28.6 (14.6-46.3) 
35/37 
94.6 (81.8-99.3) 
Negative Predictive Value of Single 
Question 
% (95% CI) 
32/35 
91.4 (76.9-98.2) 
27/24 
79.4 (62.1-91.3) 
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Figure 4 ROC curve showing performance of the single screening question for dementia 
compared to a score on the IQCODE of <3.38. 
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Figure 5 ROC curve showing performance of the single screening question for delirium 
compared to a CAM positive diagnosis. 
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Chapter 4: Service evaluation of usual cognitive 
impairment screening practice in acute care wards. 
 
4.1 Introduction 
Cognitive impairment is under-detected in older, hospitalised individuals [147]. However, 
patients with dementia or MCI are at greater risk of complications such as poor mobility, 
increased risk of falls, dehydration and incontinence, thus need specialised hospital care 
[148]. Chronic cognitive impairment is also an indicator of increased risk of delirium, 
occurring in up to 56% of these patients [149]. Delirium represents a particularly serious 
problem for hospitalised, older individual being associated with a mortality rate of up to 
76% [150].   
Hospital admission can provide an opportunity for access to older individuals who may 
not usually be so readily accessible for screening of cognitive impairment. In England 
there has recently been political intervention in a controversial attempt to improve 
detection and diagnosis of cognitive impairment in older patients through paid incentive 
[111].  
Guidelines from a number of organisations exist to direct clinicians on the preferred 
screening test(s) to use to detect cognitive impairment in medical patients. For example, 
the British Geriatric Society (BGS) [151] suggests using the MMSE [114], a clock drawing 
task [152] and the IQCODE [153], alongside a screen for delirium. This is then 
recommended to be followed by a detailed assessment for patients identified by these 
tools as at risk of cognitive impairment.   
Identification of older hospitalised patients with chronic cognitive impairment is 
important for informing decisions on capacity, to aid rehabilitation and to help detect or 
even prevent delirium and other associated complications [154]. Cognitive screening is 
the first step in this strategy.  I am unaware of current local practice – ascertaining this 
will help to develop ways to improve detection if this is identified to be necessary.  
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Local guidance followed within acute care wards at Glasgow Royal Infirmary recommends 
the use of the TIME bundle [88] (Appendix D) which promotes delirium care in acute 
wards. The TIME bundle proposes a four stage care bundle and is part of an NHS initiative 
to improve care for older patients;  
• Think- Exclude and treat possible triggers. 
• Investigate- Correct underlying causes. 
• Management- Treat all underlying causes identified above. 
• Engage- Interact with family and carers to determine if this behaviour is different 
from the patient’s baseline. Explain and document diagnosis of delirium as 
appropriate.  
However, the TIME bundle does not recommend any specific delirium or cognitive 
impairment screening tools. 
 
4.2 Research Question 
What is currently done to screen for cognitive impairment locally in acute care wards? 
 
4.3 Aim 
I aimed to determine the use of cognitive impairment screening tools in inpatients in the 
Department of Medicine for the Elderly, Glasgow Royal Infirmary. Specifically, I wanted to 
determine what methods were used to assess for cognitive impairment and delirium and 
how often a diagnosis of delirium was documented.  A secondary objective was to 
determine the proportion of patients with major barriers to completing assessments for 
cognitive impairment 
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4.4 Methods 
4.4.1 Participants 
 I was interested in examining medical records of unscheduled, acute care and geriatric 
in-patients aged over 65 years at Glasgow Royal infirmary. I used a prospective sampling 
frame, retrospectively assessing medical records of patients discharged across a 2 week 
period. Medical records were examined across a total of 9 acute geriatric in-patient 
wards within Glasgow Royal Infirmary during this service evaluation. Medical records 
were examined on the basis of patients who had completed an episode of care and had 
been discharged, died or transferred for slow stream rehabilitation within the pre-
specified two week period. Prior to the service evaluation, it was estimated that 120 
patients would meet inclusion criteria for medical record examination based on average 
hospital patient turn over. 
 
4.4.2 Target conditions 
I examined medical records for evidence of assessment for delirium, dementia and 
cognitive impairment. Tools used for all cause cognitive impairment were recorded 
during hospitalisation. Screening tool(s) used as well as the period of time after admission 
assessments were carried out was recorded. Clinical diagnoses of dementia and delirium 
were also recorded.  
Descriptive terms referring to the patients mental state, for example; “confused”, 
“cognitively impaired”, “cognitively intact” “alert and orientated” but where-by no 
cognitive assessment tool was indicated as well as terms which may be used as a proxy 
for delirium such as “acute confusional state” were recorded. No pre-specified list of 
accepted terms was specified prior to data collection.   
 
4.4.3 Procedure 
Medical records of patients who had completed a period of care within the pre-specified 
wards were examined daily Monday to Friday. Ward clerks were consulted to identify 
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relevant patient medical records. Where a ward clerk was not available, discussion with 
nurses took place.  
Once medical records were obtained, I examined their content from point of admission to 
the applicable ward. One researcher carried out evaluation of all medical records. A 
standardised data collection sheet (Appendix E) was used to collect information from 
each patient’s medical records. This information included; age, sex, date of 
admission/discharge/ death, cognitive assessments carried out, delirium noted, delirium 
diagnosis method, other suggestions of possible cognitive impairment, prior dementia 
diagnosis, usual place of residence, discharge destination, barriers to cognitive 
assessment. A numerically coded, pre-specified list of common responses was recorded 
as a key on the data collection sheet for usual place of residence, discharge destination 
and barriers to cognitive assessment. 
Suggested responses for usual place of residence were; 
1) Home 
2) Sheltered/Supported Accommodation 
3) Residential/Nursing Care Home 
4) NHS Long-Term Care 
5) Other (specify) 
This list remained the same for discharge destination but with the addition of a sixth 
potential response; “death”.  
Suggested responses for barriers to cognitive assessment were; 
1) Hearing Impairment 
2) Visual Impairment 
3) Dysphasia 
4) Unwilling 
5) Too Drowsy/Loss of Consciousness 
6) Too Unwell/End of Life Care 
7) Other (specify) 
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4.4.4 Analysis plan 
Data were analysed using statistical package for the social sciences (SPSS) Version 19. 
Demographic and clinical information was examined using descriptive statistics. 
Proportions of patients with a noted delirium diagnosis and prior diagnosis of dementia 
were of interest, as well as proportions of patients screened with specific cognitive 
impairment/delirium screening tests. 
Chi-squared test analysis was carried out to investigate if those with a diagnosis of 
dementia were more or less likely to receive cognitive assessment during hospital 
admission. 
An independent samples t-test was also carried out to assess the association between 
cognitive assessment administration and patient age.   
4.5 Results 
A total of 106 consecutive patient records were examined during this 2 week evaluation 
period with no patients missed during this assessment period. Patients were mean age 
81.3 years old (SD= 7.3) and 44.3% male.  Average length of patient hospitalisation was 
12.8 (SD=9.4) days.  
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Table 14 details proportions of the samples usual place of residence as well as discharge 
destination. The results in this table illustrate that 8/106 (7.6%) of patients did not return 
home when it was previously their usual place of residence. 4/106 (3.8%) patients died.  
Service evaluation data revealed that 89/106 (84.0%) patients had at least one cognitive 
assessment documented in the medical records in the form of the AMT 4 with 17/106 
(16.0%) patients having no cognitive assessment data recorded. The AMT 4 was the first 
documented cognitive assessment tool in all cases.  22/106 (20.8%) patients were 
screened using the MMSE and 1/106 (0.9%) patients were screened using the 
Addenbrooke’s Cognitive Examination (ACE-R) as a second documented cognitive 
assessment screening tool.  
Of the patient medical notes examined, 6/106 (5.7%) had a noted diagnosis of delirium 
with no noted method of diagnosis in any case. 33/106 (31.1%) patients had a prior 
diagnosis of dementia.  
Documented barriers to cognitive assessment were; hearing impairment 3/106 (2.8%), 
visual impairment 4/106 (3.8%), dysphasia 2/106 (1.9%), too drowsy 2/106 (1.9%).  
There was not found to be a statistically significant difference between cognitive 
assessment during admission and having a prior diagnosis of dementia (x(1)=0.80, 
p=0.36) indicating that having a prior diagnosis of dementia does not increase likelihood 
of receiving cognitive assessment during admission to the evaluated acute care wards. 
Furthermore, no statistically significant association existed between cognitive assessment 
and patient age (t(104)=1.86, p=0.66), with older age not found to increase the likelihood 
of a patient being tested for cognitive impairment during admission to acute care wards. 
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4.6 Discussion 
I found that most geriatric in-patients age 65 years and over in this service evaluation had 
at least one documented cognitive test. The prevalence of documented delirium was 
found to be low with no noted method of diagnosis in any of these cases. 
One way of measuring patient outcomes is to compare the patient’s usual place of 
residence with discharge destination with 8% of patients in this cohort not returning to 
the accommodation they came from prior to hospitalisation. 
A minority of cases had documented barrier(s) to cognitive assessment within their 
medical records. These included sensory impairments, dysphasia and being too drowsy. 
These barriers to cognitive assessment highlight what may need to be looked out for in 
future research and in clinical practice. It is important to consider possible ways to adapt 
to these to enable as many patients as possible to complete simple cognitive assessments 
such as using a conversational aid device to overcome hearing impairment. It is likely that 
these figures for barriers to cognitive impairment are higher in actual clinical practice 
than those documented. For example, sensory impairment has been shown to be viewed 
as a ‘normal’ and common part of ageing and therefore receives less attention by clinical 
staff than other conditions associated with ageing which are viewed as more ‘treatable’ 
such as heart failure and diabetes [155]. Thus, it is logical that this lack of urgency 
towards these typical barriers would transfer to what is documented within patient case 
records.    
This service evaluation revealed a low prevalence of documented delirium within older 
people in acute care. These results are not in line with local guidance which recommends 
the use of the TIME bundle [88] which promotes the documentation of delirium diagnosis. 
Delirium prevalence varies across studies investigating similar patient populations. A 
study based in Italy revealed a delirium prevalence of 12.3% using DSM-IV diagnostic 
criteria in 236 patients within an older inpatient cohort (>70 years old) [108]. Also using 
DSM-IV criteria, an Irish study revealed a prevalence of 19.6% in an acute hospital cohort 
[84]. Finally, a Thai older patient population (>70 years old) revealed a much larger 
delirium prevalence of 40.4% using DSM-IV criteria [156]. As the above studies all show 
uniformity in the diagnostic measure being used, is unclear whether this variation in 
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delirium prevalence across studies can be accounted for by cultural differences. However, 
these studies reveal that delirium is a common disorder; a conclusion which was not 
revealed by the results of this evaluation. This suggests that in usual clinical practice 
delirium diagnosis is being undocumented and perhaps under-diagnosed.  
It is important to use standardised delirium diagnostic criteria and to make note of this 
when a diagnosis is recorded within patient notes. Research has revealed that in the 
intensive care unit, where the incidence of delirium is high, objective assessment based 
on the CAM criteria by medical students identified that 38.8% of patients had delirium at 
some point during hospitalisation. Subjective nurse assessment revealed 26.1% had 
delirium during hospitalisation [157]. Furthermore, 5% (n=8) of patients within this study 
were prescribed haloperidol and lorazepam despite not meeting CAM diagnostic criteria 
for delirium due to subjectively being labelled as having delirium. These results suggest 
that a standardised criterion is important to avoid missing patients with delirium as well 
as to correctly identify those who do have delirium.   
Dementia was found to be a common and documented disorder with almost a third of 
patients noted as having a known dementia. This is in line with systematic review  
evidence [158] which revealed that published prevalence figures of dementia in older 
hospitalised patients (>55 years old) ranged from 12.9%-63.0%, taking in to account only 
studies which used robust methodologies. This evidences that dementia is a common 
disorder within older, hospitalised patients.  
The results of this evaluation are strengthened by a prospective, consecutive sampling method 
which ensured that all patient case-notes were able to be accessed within a pre-specified time 
frame. This was carried out over a total of nine wards spanning all older acute care in-patient 
wards within the target hospital, thus reducing risk of any results being due to specific clinician 
practice.  
I exclusively examined all patient case-records thoroughly, reducing likelihood of missing 
information if multiple individuals with less commitment to the project or less familiar with the 
topic were involved in this process.  
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It is important to note that results from this service evaluation are not generalisable to 
other hospital or patient settings but only represent current practice at the target 
hospital and during the specific time period it took place.  
My results inform future research and highlight that delirium documentation and 
detection is an area within this particular hospital setting is an area which promptly 
requires further attention. This is required both in relation to the screening and diagnosis 
of delirium, with both going unrecognised within this evaluation. 
While the results of this service evaluation reveal that dementia is a common disorder 
within older acute care patients, delirium is not found to be as well documented within 
patient case notes. The prevalent nature of dementia is important when considering the 
complex relationship between delirium and dementia. A longitudinal study [159] which 
tracked more than 500 individuals across a 10 year period found that those who 
previously had delirium, three quarters of these patients went on to develop dementia 
compared to a third of those who did not have a history of delirium. It was found that 
delirium in those with existing dementia accelerated the severity of dementia. It is 
important to note that these results were found in individuals age 85 and over. Building 
on this, further research should explore whether the prevention and/or swift 
management of delirium by identifying the underlying cause can lead to the reduction of 
patients developing dementia or reduction in the dementia progression for those who 
already have this disorder. However, this is not possible unless delirium is diagnosed and 
documented effectively. 
4.7 Conclusion 
It was found that while screening of cognitive impairment was completed in a vast 
majority of patients, there was no documented screening or diagnosis of delirium in the 
acute care wards within this service evaluation. While it is not optimal to diagnose a new 
dementia during hospital admission when a patient is likely not functioning at their 
cognitive baseline, delirium on the other hand is a disorder which is ideally diagnosed and 
resolved before discharge.                                                                                                                                                                                             
Results from this service evaluation show that clinicians give higher priority to the 
documentation of dementia but this also needs to be the case for delirium. 
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Table 14 Proportion of patients’ usual place of residence and discharge destinations. 
 
 Usual place of residence  
 
Discharge destination 
Home N (%) 
 
82/106 (77.4%) 74/106 (69.8%) 
Sheltered/supported 
accommodation N (%) 
8/106 (7.5%) 7/106 (6.6%) 
Residential/nursing care N (%) 
 
15/106 (14.2%) 19/106 (17.9%) 
NHS long term care N (%) 
 
1/106 (0.9%) 2/106 (1.9%) 
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Died N (%) 
 
n/a 4/106 (3.8%) 
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Chapter 5: National clinician survey of cognitive 
screening in the acute care hospital setting.   
 
5.1 Introduction 
Guidelines from a number of organisations exist to direct clinicians on the best screening 
tests to use to detect cognitive impairment in medical patients. The updated NICE 
dementia guidelines (April 2015) [160] suggest that the ACE-R appears to have better 
diagnostic test accuracy for the screening of dementia compared to the widely used the 
MMSE [161-164], and that the ACE-III may also show promised but requires further 
validation [164]. It is recommended that dementia assessment should take place 
alongside a delirium screening tool, supplemented by relative/carer report.  
This statement is aligned with local policy. The Scottish government has implemented a 
two year programme titled ‘Improving the care for older patients in acute hospitals’ [88]. 
In terms of cognitive impairment, this programme particular focuses on the detection of 
delirium, claiming the disorder to be a prevalent ‘medical emergency’. The Scottish 
government provide a ‘Delirium toolkit’ aimed to improve delirium detection rates in 
acute care. The toolkit operates under the heading ‘Think Delirium’ and suggests that a 
local delirium screening tool should be used, a cognitive impairment screening tool as 
well as an informant based screening tool which gathers patient history from a relative, 
carer or close friend. Although suggestions are made of possible screening tools to be 
used, no one specific measure is suggested for each form of assessment, instead 
referencing the use of a ‘local tool’.  
A variety of other guidelines exist for the screening of cognitive impairment which 
contains their own specific suggests of which screening tools should be used. The BGS 
guidance for the prevention, detection and management of delirium [151] suggests that 
all patients over the age of 65 should be screened for cognitive impairment on admission 
using the AMT or MMSE. The BGS then goes on to suggest that all patients identified by 
these tools as having cognitive impairment as well as other at risk groups including the 
severely ill, those with sensory impairment and those with dementia should be assessed 
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for delirium using the CAM. These guidelines were first published in 2006, thus the 
suggested screening and diagnostic tools may be outdated.  
The Alzheimer’s Society provides a ‘cognitive assessment toolkit’ [165] to help aid clinical 
assessment of cognitive impairment. This tool kit provides specific guidance for use in the 
acute care setting suggests an initial, brief assessment using the CQUIN SSQ ‘insert 
question’, followed by the AMT 10 and/or the General Practitioner Assessment of 
Cognition (GPCOG) and/or Six-item Cognitive Impairment Test (6CIT). It is suggested this 
should be supplemented with the CAM for the diagnosis of delirium.  
The range of guidelines available and conflicting suggestions of which screening tool 
should be used for the detection of possible cognitive impairment may cause confusion 
among clinicians of the best way to go about this. It is of interest to determine which of 
these guidelines are followed nationally, if any.  
5.2 Research Question 
Which tools are used to screen for cognitive impairment in Scottish acute care wards? 
5.3 Aim  
To identify what clinicians report is being used to screen for cognitive impairment across 
Scotland to determine if there is consensus between Scottish hospitals. Current tools 
used as well as how well clinicians believe these tools are used in practice are of interest.  
5.4 Methods 
5.4.1 Target population 
In the first instance, every hospital within Scotland with a geriatric in-patient department 
was identified. Following this, the lead clinician was identified within each unit. This was 
done using knowledge of on-site clinicians at Glasgow Royal Infirmary and supplemented 
by internet searches where necessary. Email addresses for each lead clinician were 
identified in the same way. In cases where email addresses were not listed on the 
hospital website, telephone calls were made to the request email address information. 
The questionnaires were sent by email to all clinicians on the same day with one further 
email reminder sent two weeks if no response had been received. 
73 
5.4.2 Measures 
A short questionnaire (Appendix F) was sent to the lead clinician within each hospital. 
This questionnaire was first piloted with local geriatric clinicians at Glasgow Royal 
Infirmary who were requested to give qualitative input regarding how the length, 
response format and items of the questionnaire. Questions focused on; what tools are 
being used, whether guidelines are followed and how well cognitive impairment is 
screened for in older patients. The questionnaire consisted of five separate items with a 
combination of open and closed response options. The questions were designed to fit on 
one A4 sheet to encourage a good response rate. Respondents had the option to return 
the questionnaire by email or post. 
 
5.5 Results 
I received 18 responses of a possible 23 (78%). Of the respondents, all but one stated that 
guidelines exist within their unit for screening of cognitive impairment for older patients 
(>65 years). A variety of tools were identified as being used for the screening of cognitive 
impairment with most respondents (83%) stating that more than one tool is used within 
their unit. The most commonly used tool was the MMSE (56%), followed by the AMT 4 
(50%) and the 4AT (39%). The ACE-III & ACE-R, the MoCA and the Mental Status 
Questionnaire (MSQ) were also highlighted as being used for cognitive impairment 
screening in selected older, hospitalised patients (Table 15). This figure provides a colour 
coded map of responses given for cognitive impairment screening tool used. This figure 
illustrates that there is an even spread of the tools used, with no tools appearing to be 
area specific. 
Clinicians were also asked what diagnostic tool(s) they used for the detection of delirium, 
if any ( 
Table 16).  Four tools were identified; 4AT (56%), the CAM (28%), SQiD (11%) and the 
DSM-IV criteria (6%). However, 33% of respondents stated they used clinical judgement 
alone or had no criteria for the detection of delirium. Figure 6 provides a colour coded 
map of responses given for delirium screening tool used.  This figure illustrates that there 
is a strong presence of the use of the 4AT within the south east of Scotland as well as the 
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CAM exclusively being used in this area for the screening of delirium. Furthermore,  there 
is a lack of specific screening tool being used within the West of Scotland, highlighted as 
the only area which relied on clinical judgement/no criteria.  
Finally, clinicians were asked to rate how well they thought screening for cognitive 
impairment was carried out within their unit on a Likert scale ranging from 1 (‘poor’) to 5 
(‘excellent’). Results showed an average rating of 3.9 with no respondent rating below a 3 
(‘average’). 
 
5.6 Discussion 
I received a reasonably good response rate from lead clinicians in geriatric units across 
Scotland, receiving over three quarters of clinician surveys back by email. This was 
particularly the case within the East and West of Scotland, with less clinician 
representation in the North of Scotland.   
While almost all respondents stated their unit had formal guidelines, there is notable 
heterogeneity in tools being used to screen for cognitive impairment in Geriatric Units in 
Scotland. It appeared that there may be some confusion over which is the best cognitive 
impairment screening tool to use, with the vast majority of respondents citing more than 
one tool. However, it may be the case that it is more suitable to employ a multi-tool 
approach to assessment of cognitive impairment with a very brief screening tool used 
first such as the AMT 4 followed by a more detailed tool such as the MMSE or MoCA if 
the initial screen prompts further assessment. However, there were a variety of tools 
used and it appears that these were evenly spread through-out Scotland for the 
screening of cognitive impairment, with no tools appearing to be specific to be region 
specific. It is unclear whether this heterogeneity is due to a range of effective tools being 
available for cognitive screening or due to confusion over which tool should be used 
within acute care.  
These results are supported by heterogeneity in approach to cognitive assessment also 
found in a larger scale survey of 174 clinical staff across Scotland within the stroke 
hospital setting [166]. This study revealed that a total of 45 different cognitive 
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assessment tools were stated as being used across Scottish stroke wards, suggesting lack 
of uniform assessment is not just apparent within the acute care setting.  
An important finding was the lack of formal screening for delirium. It was found that a 
third of respondents did not have a delirium screening criteria or used clinical judgment 
alone. This was only found to be the case within the West of Scotland suggesting there 
may be a lack of local guidance for the assessment of delirium within this region. There 
appears to be a need for an evaluation of delirium screening in acute care in-patients in 
this region to determine which assessment tool clinicians should use.   
Furthermore, there was clear preference for use of the 4AT within the East of Scotland. 
The 4AT is a local tool which was developed in Edinburgh, which may explain it is 
predominantly used within this region. However, at the time this clinician survey was 
carried out, there were no published validation studies of the 4AT (January 2014). Also, 
the only clinicians who claimed to use the CAM were in the East of Scotland. This may be 
regarded as an outdated delirium assessment tool as it is based on DSM-IV published in 
2008 [112]. There has since been a further publication of diagnostic criteria (DSM 5) [14]. 
It could be argued that using the 4AT and CAM is better than carrying out no formal 
assessment of delirium, as clinicians claim to be the case in the West of Scotland.  
Another Scotland-wide survey carried out in 2013 across acute stroke units revealed 43% 
of clinicians stated they used clinical judgement when identifying delirium [167]. This is 
despite evidence that clinicians are not good at picking up cognitive impairment, 
including delirium, when based on non-structured assessment alone [168].  
However, in general clinicians’ feel cognitive screening is being carried out to an 
adequate standard. This does not agree with a Scottish government audit of cognitive 
impairment assessment in hip-fracture patients carried out during the same period of 
time as this clinician survey (December 2012-March 2013) [169]. This audit revealed that 
in NHS Fife, less than half of patients had any cognitive assessment documented at all and 
that only 30% of patients had cognitive assessment carried out within the first 24 hours.   
It is important to note a potential weakness to the methodology of this sampling when 
deciding to only approach lead clinicians from each acute care unit in Scotland rather 
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than a variety of clinicians working within each unit. Only approaching one member of 
each acute care unit means that it is not possible to compare responses from others 
within each area and may provide a skewed impression of what one individual thinks is 
being done within their unit as well as only providing one opinion of how well clinicians 
feel cognitive screening is being carried out at that hospital. Furthermore, if multiple 
individuals were sent a questionnaire within each hospital this may have lead to a higher 
percentage of responses from all areas, rather than relying on one single clinician to reply.  
I suggest that further research is required to inform development of a standardised 
assessment protocol of cognitive impairment including delirium in older hospitalised 
patients across Scotland.
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Table 15 Screening tool frequency with percentage of hospitals citing this tool for the 
detection of possible cognitive impairment. 
MMSE=Mini-Mental State Examination, AMT= Abbreviated Mental Test, 4AT=4 A’s Test, 
ACE=Addenbrooke’s Cognitive Examination, MoCA=Montreal Cognitive Assessment, MSQ=Mental 
Status Questionnaire. 
 
 
 
 
 
MMSE  AMT4 4AT AMT10 ACE-III/ACE-
R 
MoCA MSQ 
10 (58%) 9 (53%) 7 (41%) 6 (35%) 5 (29%) 5 (29%) 1 (6%) 
78 
 
Table 16 Screening tool frequency with percentage of hospitals citing this tool for the 
detection of possible delirium. 
4AT No criteria/ clinical 
judgement 
CAM SQiD DSM-IV 
10 (59%) 6 (35%) 5 (29%) 2 (12%) 1 (6%) 
4AT=4 A’s Test, CAM=Confusion Assessment Method, SQiD=Single Question in Delirium, DSM-
IV=Diagnostic and Statistical Manual 4
th
 edition.  
 
 
 
Figure 6 Scotland map illustrating delirium screening tool use by region. 
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Chapter 6: Evaluation of delirium screening tools 
in geriatric medical in-patients. 
 
6.1 Overview  
There are a variety of methods available to clinicians to aid the diagnosis of delirium 
which have shown excellent performance in the research setting [170-171]. The CAM is 
the most widely used instrument for the detection of delirium both clinically and within 
research [16,18]. The CAM is a brief tool designed to take 5-10 minutes to complete, has 
been translated in to 10 languages and has been found to have excellent sensitivity (93%-
100% and specificity (98%-100%) [172]. However, these high sensitivities do not seem to 
transfer to the routine clinical setting when administered by nurses at the bedside (19-
47%) [173-175].  
The fifth revision of the DSM 5 [14] provides an updated definition of criteria individuals 
should fulfil for a diagnosis of delirium. DSM 5 criteria defines the core features of 
delirium to be impaired awareness, inattention, acute onset, fluctuating course as well as 
an additional cognitive impairment such as memory or language. These impairments 
should be evidenced by a physically evident cause and not better explained by an existing 
disorder. The European Delirium Association and American Delirium Society made a joint 
proposal for an amendment of DSM 5 delirium criteria [176]. They suggested that in 
order to make this diagnostic criteria more inclusive, patients who are unable to 
complete direct cognitive testing due to reduced level of arousal should be classified as 
having inattention and evidence suggest that this patient group are likely to have a 
delirium [177]. 
While the DSM 5 delirium diagnostic criteria go some way towards standardising and 
aiding the delirium diagnosis process. Published guidance recommends that all older 
adults admitted as an emergency to hospital should be assessed for possible delirium 
[160]. It is not feasible or appropriate for all adults to undergo a very detailed assessment 
of cognition. Brief screening tools that can be carried out by nursing staff throughout the 
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day are therefore important in the detection of possible delirium. However, there is no 
consensus on how this assessment should be performed.    
 
6.2 Research Question 
Which cognitive/delirium screening tools recommended for routine use with older 
inpatients in Greater Glasgow & Clyde are effective for the screening of delirium? 
 
6.3 Aim 
This project aimed to evaluate the test accuracy of routinely used brief cognitive 
assessment tools for detection of a clinical diagnosis of delirium. The feasibility and 
diagnostic test accuracy of delirium screening tools will be assessed.  
 
6.4 Methods 
6.4.1 Participants 
I recruited a consecutive cohort of non-elective patients in an urban teaching hospital. 
Patients were >65 years old and being cared for in GAU’s. The GAU offers comprehensive 
assessment to older adults following triage in an acute medical unit. All patients under 
the care of 6 senior elderly-care physicians were eligible for evaluation.  
I used routine health-care data collected as part of a departmental service evaluation and 
service improvement initiative looking at delirium assessment. Approval to access, collect 
and analyse NHS data for this study was obtained from the Caldicott Guardian (Appendix 
G & H).  The components of the cognitive tests which I used were all recommended for 
routine clinical use in the assessment of older people in the Rehabilitation and 
Assessment Directorate of Glasgow and Greater Clyde. In reporting our project, I 
followed best practice guidance as described in the dementia specific extension to 
STAndards for the Reporting of Diagnostic accuracy studies [178].  A service evaluation 
approach was used in this study rather than a research project as, given the inconclusive 
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nature of existing empirical evidence; it was not deemed that any screening tools not 
recommended for routine clinical use were required to be evaluated at this point. While 
this prevented the expansion of the project beyond these recommended screening tools, 
it allowed for an efficient evaluation of these in a large number of patients who should 
have been receiving cognitive and delirium screening during this time period regardless.  
6.4.2 Index tests 
Index tests for cognitive impairment recommended for routine use in this population 
were of interest to this study. These encompassed the AMT [129], 4AT [108], bCAM [91] 
and the SQiD [106]. MOTYB is a component of the 4AT and bCAM and was also 
considered separately as a standalone index test. These screening tests included routine 
information from direct patient testing (18 items) as well as informant report from 
relatives and on-duty nurses.  
 
AMT 10/4 [129, 179] 
This is a ten item tool developed for the assessment of cognitive impairment. Patients 
gain a point for every correct answer, with a total score calculated out of ten. A shorter 
version of this tool can also be administered asking only four of the ten AMT 10 questions, 
namely the AMT 4 (Appendix I). The shorter, four item version may be as effective as the 
full AMT 10 at detecting possible cognitive impairment (MMSE<24) [180]. This tool was 
not developed specifically for the screening of delirium, thus no validated cut-point has 
been established. A score of <7/10 has been found to have good diagnostic test accuracy 
when screening for a significant cognitive impairment [168]. 
 
4AT [108] 
A brief screening tool designed for the detection of possible delirium as well as cognitive 
impairment. This tool has 4 separate domains which measure alertness, AMT 4, attention 
and acute change/fluctuating course. The tool has a maximum score of twelve with a 
higher score indicating increased impairment (Appendix J). The 4AT has been validated in 
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two studies; in a sample of 234 older in-patients and in a separate study of 111 stroke 
patients [108, 120].  
 
bCAM [91] 
This is a two stage screening method for delirium (Appendix K). In the first stage the 
patients’ level of consciousness (direct observation) and inattention (Spelling ‘lunch’ 
backwards) are assessed. Patients with disturbed consciousness or more than one 
spelling error proceed to a second stage including assessment of inattention (MOTYB) 
and disorganised thinking assessed through direct patient testing (6 short questions). This 
tool is intended to be a short and pragmatic operationalisation of the CAM, a method of 
delirium diagnosis which uses DSM IV criteria.   
 
SQiD [106] 
An SSQ for delirium to be directed at a relative, carer or close friend of the patient. The 
question asks; “Has your friend/relative been more confused lately?” with a 
dichotomised response method, yes or no.  
 
6.4.3 Reference standard 
Elderly care physicians used a standardised checklist when diagnosing delirium and 
dementia. This checklist was based on the fifth edition of the DSM 5 criteria for delirium 
[14] (Appendix L) and the fourth edition of the DSM-IV criteria for dementia [113] 
(Appendix M).  
Clinicians had 3 choices when considering the diagnosis of delirium;  
i) Delirium (meeting all DSM-V criteria) 
ii) Possible delirium (‘don’t know’ clinician response for one or more DSM-V 
criteria, with all other criteria met)  
iii) No delirium (any DSM-V criteria not met).  
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For dementia diagnosis, if the patient had a prior diagnosis of dementia then the checklist 
was not required and the clinicians marked this on the sheet. If the patient did not have a 
prior diagnosis of dementia then the clinician assessed the patient as either;  
i) New dementia (meeting all DSM-IV criteria) 
ii) Possible dementia (‘don’t know’ clinician response for one or more DSM-IV 
criteria, with all other criteria met) 
iii) No dementia (any DSM-IV criteria not met). 
For the purposes of this evaluation, it was decided that DSM-IV criteria for dementia 
would be used as there was some uncertainty among involved clinicians over the 
relatively new DSM 5 dementia criteria; the disorder itself being renamed as major 
neurocognitive disorder. DSM-IV criteria was still current clinical practice for the 
diagnosis of dementia at the time of this evaluation.  
Clinical assessment was performed as part of routine clinical care. This initial clinician 
assessment was blinded from index test results.  
 
6.4.4 Procedure 
The routine data required to populate the index test assessments were administered and 
collated by a single observer blinded from elderly care clinician assessments until all index 
test scoring was completed. Index test assessment was aimed to be completed within 
two hours of clinician assessment.  
Direct patient assessments consisted of 18 items. Items which overlapped between index 
tests such as MOTYB and the AMT 4 were only administered once per patient. There 
were also three questions to be asked of a nurse familiar with the patient and two 
questions to be answered by a relative or carer. The order of testing was fixed for all 
patients (Appendix N).  
Direct patient testing duration was timed to the nearest second using a stop-watch. 
Following patient assessment, any barriers to the patient’s ability to complete any part or 
all of the cognitive assessment procedure was recorded such as hearing impairment, 
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dysphasia, and medical instability. A headset with amplifier was also made available to 
patients with hearing impairments. Patient test duration was timed using a stop-watch.  
Informant data from nurses was collected as soon as possible after direct patient testing. 
Following this, an A4 sheet of paper detailing the nature of the investigation and two 
SSQ’s (Appendix O) for delirium (SQiD) and cognitive impairment (SSQ used within the 
CQUIN framework) was left with the nurse to be passed on to a relative, friend or carer to 
be completed the same day, where possible.  
I obtained clinical and demographic information from patient case-notes following 
assessment. This included age, sex, date of admission, main symptom(s) at presentation, 
and barriers to communication (including deafness, visual impairment, and dysphasia).   
Information obtained from direct patient testing was fed back to the relevant clinician on 
the next ward round to inform the patient care process.  
Direct patient screening and clinician assessment of delirium was performed once per 
patient. 
 
6.4.5 Analyses 
Subjects were categorised according to delirium diagnosis (definite, possible, no delirium).  
Differences in clinical and demographic features between the three groups of patients 
were described using Kruskal-Wallis H test analyses. Where data suggested a between 
group difference, I used Mann Whitney U analysis to confirm differences between two 
groups. 
I described test accuracy statistics of sensitivity, specificity, positive and negative 
predictive values and corresponding 95% confidence intervals; comparing the routine 
cognitive index tests (AMT-10, AMT-4, 4AT, bCAM, MOTYB and SQiD) against the 
reference standard of consultant elderly care physician diagnosis of delirium (DSM V).  
For the 4AT, a pre-determined threshold of <4/12 was used. The bCAM and SQiD were 
both dichotomised as positive or negative outcomes. Sensitivities and specificities were 
also calculated for each individual score on MOTYB ranging from 0 to 12.  
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ROC analyses were carried out separately on all index tests, comparing to reference 
standard DSM-V delirium diagnosis. ROC analyses were used to select optimal cut-point 
for screening tests which did not have an agreed cut-point specifically for delirium based 
on existing literature (AMT-10/-4, MOTYB). Data were analysed separately for delirium 
only diagnosis (table 2) and a composite of delirium and possible delirium diagnosis (table 
3). 
ROC analyses were carried out separately for each for the 4 components of the 4AT; 
altered alertness, AMT 4, MOTYB and acute change/fluctuating course. Analyses were 
carried out in accordance with the 4AT scoring system. 
All analyses were performed using SPSS for Windows (version 22.0; SPSS, Armonk NY, 
IBM Corp.)   
 
6.5 Results  
6.5.1 Main analyses 
I assessed 500 patients over an 8 month period. Clinicians completed assessment of 
delirium in 94.8% of patients (474/500) with 1.6% (8/500) not assessable and 3.6% 
(18/500) patients not seen by study clinician during the assessment period. Patients were 
87% female (433/500); mean age 83.1 years (SD= 6.7) ( 
 
Table 17). Patients were tested a median of 2 days after admission (IQR=1-3). 
Reference standard: Using DSM-V delirium criteria, 18.6% (93/500) patients had definite 
delirium, 20.8% (104/500) possible delirium and 55.4% (277/500) no delirium (Figure 7).  
30% (150/500) of patients had a prior diagnosis of dementia and 4% (22/500) received a 
new diagnosis of dementia (DSM-IV criteria). 
Index tests: Index test assessment took place in a mean time of 50 minutes (range=0-105 
minutes) from clinician delirium assessment. Direct patient assessment took a mean total 
time of 4.8 minutes (range= 4-7 minutes). 
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Barriers to direct cognitive testing were noted in 17.8% (89/500) of patients. Within this 
group of patients, 4.8% (24/500) had a level of dementia which prevented understanding 
of instruction, 3.8% (19/500) were too drowsy to be assessed at all, 2.8% (14/500) had a 
hearing impairment which could not be overcome by a hearing amplifier, 2.4% (12/500) 
were deemed by the elderly care physician as too unwell or inappropriate for direct 
cognitive assessment (e.g. terminal care), 1.8% (9/500) were dysphasic, 1.6% (8/500) 
were unwilling to answer assessment questions and 0.6% (3/500) were blind. 
I was able to obtain a total score on the 4AT in 86.8% (434/500) of patients; on MOTYB in 
84.2% (421/500); on the AMT 10/AMT 4 in 81.6% (408/500); and on the bCAM in 77.4% 
(387/500). Data was obtained from relatives or carers for 28.2% (141/500) of patients 
using the SQiD.  
Figure 7 provides a flowchart detailing complete and incomplete delirium diagnoses as 
well as total numbers of patients who were able to complete each index test. 
Mean scores on the AMT 10, AMT 4, 4AT and MOTYB were presented by delirium 
diagnosis in Table 18 and Figure 8 as well as dementia diagnosis Table 19 and Figure 9.  
ROC analyses were carried out to assess diagnostic accuracy of the index tests when 
comparing to a definite diagnosis of delirium. The AMT 10 was found to have a sensitivity 
of 86.6 and specificity of 63.5 at a cut-point of <4/10. The AMT 4 was found to have a 
sensitivity of 92.7 and specificity of 53.7 at a cut-point of <3/4. The 4AT was found to 
have a sensitivity of 86.7 and specificity of 69.5 at a cut-point of >4/12. The bCAM was 
found to have a sensitivity of 70.3 and specificity of 91.4. MOTYB was found to have a 
sensitivity of 91.3 and specificity of 49.7 at a cut-point of <5/12. The SQiD was found to 
have a sensitivity of 91.4 and specificity of 61.3. See Table 20 for further detail. ROC 
curves for patients with definite delirium are displayed in Figure 10. 
ROC analyses were carried out to assess diagnostic accuracy of the index tests when 
comparing to a definite diagnosis of delirium or possible delirium (combined as ‘delirium’ 
group). The AMT 10 was found to have a sensitivity of 76.4 and specificity of 72.9 at a cut-
point of <4/10. The AMT 4 was found to have a sensitivity of 85.1 and specificity of 63.6 
at a cut-point of <3/4. The 4AT was found to have a sensitivity of 69.8 and specificity of 
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76.7 at a cut-point of >4/12. The bCAM was found to have a sensitivity of 45.6 and 
specificity of 95.0. MOTYB was found to have a sensitivity of 82.4 and specificity of 61.5 at 
a cut-point of <5/12. The SQiD was found to have a sensitivity of 71.0 and specificity of 
66.7.  See Table 21 for further detail.   
For the MOTYB cognitive assessment, it was found that 23.3% were able to complete all 
12 months in the correct order. A score of 0/12, where the patient did not get any of the 
MOTYB in the correct order, had a larger number of patients than any other single score 
with 25.2% (126/500). A cut-point of <5 (i.e. this is the number of consecutive months 
correctly recited in backwards order starting at December) provided a sensitivity of 91.3% 
with a specificity of 49.7.   
 
6.5.2 Further analyses I 
Further analyses were carried out to determine the diagnostic test accuracy of each of 
the 4 components of the 4AT separately.  
ROC analyses revealed that of the 4 components of the 4AT, acute change/fluctuating 
course had the greatest diagnostic test accuracy (AUC=0.80) and altered alertness the 
lowest (AUC=0.55). Sensitivities ranged from 94.4% for MOTYB to 14.4% for altered 
alertness. Specificities ranged from 95.3% for altered alertness to 39.6% for MOTYB 
(Table 22). 
 
6.5.3 Further analyses II 
I evaluated the reasons for diagnostic uncertainty in attending clinicians by looking at the 
frequency of ‘don’t know’ responses to DSM 5 criteria for patients with ‘possible delirium’ 
(n=104) (Table 23).  
Clinicians were most unsure about whether a patient has shown a change from baseline 
(n=65), if there has been fluctuation in severity (n=57), acute onset of delirious symptoms 
(n=56) and whether the symptoms could be better explained by another pre-existing, 
established or evolving neurocognitive disorder (n=51). There were few patients where 
clinicians were unsure of whether they had altered attention (n=5), altered awareness 
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(n=11), additional disturbance in cognition (n=13) or whether the symptoms occurred in 
the context of a severely reduced level of arousal such as coma (n=3).There were no 
cases where clinicians were unsure that there was evidence that the disturbance had a 
direct physiological cause.  
98/104 of patients identified as ‘possible delirium’ had a possible or existing dementia, 
with 6/104 patients having no dementia. Specifically, 57 (54.8%) patients had a prior or 
new dementia, 41 (39.4%) had a possible dementia and 6 (5.8%) of patients had no 
dementia. All patients had a mean of 2.5 items on the DSM-V criteria checklist marked as 
“don’t know”, those with a new or prior dementia had a mean of 2.5 items marked as 
“don’t know”, a mean of 2.8 items for those with possible dementia and a mean of 1.3 
items for those with no dementia.  
 
6.6 Discussion 
I found that brief cognitive screening tests, including AMT10, AMT4, MOTYB and 4AT, had 
good sensitivity for detecting definite delirium, above 86%. However the specificity of 
these assessments for definite delirium was lower, ranging from 53 to 70%. These figures 
are reflected in the negative and positive predictive values, with good negative predictive 
value (over 95%) but poor positive predictive value (40% or less).  Amongst these 
assessments using the full AMT-10 seemed to carry no advantage over the subset of 
questions in the AMT-4, with very similar diagnostic performance characteristics. The 
bCAM appeared to demonstrate notably lower sensitivity. Thus, bCAM appeared to be 
less appropriate as a screening tool for delirium as a test with high sensitivity is essential 
when screening. 
The above brief cognitive assessments appeared to be feasible in this cohort, although 
common barriers to assessment (severe illness, depressed conscious level, inability to 
respond to instruction) prevented direct assessment of cognition in around 1/5 cases.  
The informant-based SQiD showed promise as a screening assessment, with high 
sensitivity and good negative predictive value, however it proved difficult to obtain these 
data with informant responses obtained in less than 30%.  
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While the AMT 10 and AMT 4 were not originally designed for the screening of delirium, 
both were feasible screening tools within this population. The AMT 10 did not appear to 
perform better than the AMT 4 for the screening of delirium. Further validation is needed 
to establish optimal cut points.  
MOTYB appeared to be a difficult task for patients in this population with less than 
quarter receiving full marks and a quarter unable to recite any of the months in the 
correct order. This may be due to the high proportion of patients with dementia in this 
study. A recent study in which MOTYB was assessed in a population of elderly patients 
without dementia found that 87% were able to recite all 12 months [181].  
Using MOTYB as a screening tool for delirium in a population where dementia is 
prevalent showed high sensitivity but low specificity. It is unclear from existing literature 
what the optimal cut point for this tool should be. This investigation revealed low cut 
points of 3 or 4 out of 12 appeared to have best diagnostic test accuracy.  
MOTYB did appear to be a sensitive and very brief tool when screening for delirium in this 
sample of older, acute care patients. Further research is necessary to examine the best 
way to score this test. It may be appropriate to use this test alongside another brief 
screening test for delirium to improve specificity. A recent systematic review examined 
existing evidence for use of MOTYB across clinical and research settings and found it to 
be sensitive to significant cognitive impairment as a whole. However, it was concluded 
that there was a lack of consistency when rating and administering this test across studies 
[182]. A clear assessment procedure is necessary for use with MOTYB, for example to 
clarify if patients should or should not have the opportunity to self-correct.  
Separate analysis of the 4 components which make up the 4AT revealed that alertness, 
AMT 4 and MOTYB were highly feasible using the 4AT scoring system. The scoring for the 
4AT allowed for a larger proportion of patients to be scored compared the standard 
scoring of the AMT 4 and MOTYB in this evaluation.  This is due to the 4AT giving patients 
a score even if they are unable to attempt these direct cognitive testing components. 
Simplifying the MOTYB scoring system to indicate patients with a score of less than 7 out 
of 12 or unable to attempt as showing impairment on this task may be more feasible but 
loses a lot of valuable information than when scoring individually. However, this 
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simplified scoring may be more suitable for a rapid screening tool of delirium. The 
alertness component of the 4AT showed very poor sensitivity but boosts the overall 
specificity of the tool, with a high individual specificity. The AMT 4 and acute 
change/fluctuating course components had good diagnostic test accuracy. 
The performance of the bCAM as a screening test for delirium appeared to be less good, 
with poor sensitivity, missing around 3 in 10 patients with delirium. However it had good 
specificity at over 90%. Therefore the bCAM might have a role as an assessment to detect 
patients with definite delirium for research studies (few false positives), but it appears 
not to be appropriate as a clinical screening test for the acute medical condition of 
delirium (too many false negatives).   
While the SQiD showed promise as a very brief screening tool with high sensitivity which 
required no direct patient contact, it did not appear to be feasible within this cohort. It is 
likely the number of responses would have been higher if testing had been carried out 
over a number of days rather than at one point in time whereby an informant response 
was necessary within that same day. However, due to the fluctuating nature of delirium it 
is necessary to screen regularly, yet evident from this evaluation that it is not always 
possible to get quick and easy access to a relative or close friend within the acute care 
environment. The SQiD may be more appropriate as a supplementary delirium screening 
tool along-side brief direct cognitive testing, in patients where this is possible to be 
obtained.   
This study was conducted following results obtained from service evaluation of what was 
currently being done to screen for delirium at Glasgow Royal Infirmary (chapter 4) as well 
as Scotland-wide clinician survey of cognitive screening, including delirium (chapter 5). 
Both revealed a local problem of a lack of both delirium diagnosis being carried out and 
delirium screening tools being used. I presented the results of this evaluation orally to the 
Delirium Short Life Working Group with the aim of feeding in to local delirium screening 
policy by providing evidence from a large, representative cohort of older in-patients 
within Glasgow Royal Infirmary.  
This study showed that there was often uncertainty in the diagnosis of delirium, even by 
experienced clinicians with an interest in cognitive impairment. A comparable proportion 
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of patients were diagnosed with possible delirium as were identified as having definite 
delirium. This diagnostic uncertainty may have been more apparent as elderly care 
physicians were asked to make a diagnosis of delirium at a single point in time early in the 
patient’s admission. Diagnostic uncertainty is likely to be less if patients are followed over 
time, gathering more information and with a more prolonged period of observation of 
symptoms as well as behaviours. However even allowing for this it is clear that diagnostic 
uncertainty is a major issue which is generally under-recognised within the current 
literature, where there is often a focus on making a definite yes or no delirium diagnosis. 
The use of a “possible delirium” label may be useful for elderly care physicians within the 
hospital setting. 
It was found that almost half of those marked as possible dementia were diagnosed with 
delirium.  This highlights the difficulties of diagnosing a chronic cognitive impairment such 
as dementia in the acute care environment in which patients are more likely to have 
complications such as delirium and other illnesses which would either not be present or 
less severe when returned to the community setting. As would be expected, a low 
proportion of those with no dementia had delirium. 
Our findings are generally consistent with the published literature. A delirium prevalence 
as found in this cohort of 19% is in line with other recent reports of older hospital 
inpatients. A meta-analysis of 42 studies reported delirium prevalence in medical in-
patients to be 10-31% [183].  
The 4AT was investigated as a delirium assessment tool in a consecutive sample within 
acute care in Italy (n=236) [108]. In this study, the 4AT was found to have a sensitivity of 
90% and specificity of 84%. I found a similar sensitivity although specificity in our study 
was not as good. This study did not compare the 4AT with other brief cognitive 
assessments so may present more accurate diagnostic test accuracy of the tool as a 
stand-alone screening test for delirium. Other investigators have reported better 
performance of the 4AT; this assessment has been reported to have very high sensitivity 
(100%) and good specificity (82%) within the acute stroke unit setting [120]. This 
enhanced 4AT performance was found in a different clinical population to the one 
evaluated here, specifically patients recovering from stroke. Furthermore, this was in a 
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smaller patient sample (n=108) than our study and carried out within a much smaller 
time frame (10 weeks vs. 8 months), with multiple researchers carrying out index tests.  
There is limited validation data published on the bCAM. It has been tested in an 
emergency department sample of 406 patients. Despite this tool being used within a 
different clinical context, researchers found similar test accuracy to our data with poor 
sensitivity and a missed delirium diagnosis in around 1 in 5 patients, but claimed excellent 
specificity of 97% [91].  
The results of this study are strengthened by a relatively large sample of consecutive 
patients across multiple acute care wards. Also, results are made more reliable by a 
blinded methodology with completely separate assessors carrying out index tests from 
reference standard diagnosis. Experienced elderly care physicians carried out the most up 
to date delirium diagnostic criteria (DSM 5) using a standardised assessment method, 
recorded for each individual patient. This reference standard mirrors recommended 
clinical practice. 
I acknowledge the limitations of this study. The index tests were combined to form a 
short program of questions performed in a fixed order of testing.  Individual screening 
assessments may perform differently if used in isolation and there is the risk of potential 
contamination of results between different screening questions. Our project was 
designed to describe clinical practice in a single site, an urban teaching hospital in an area 
of high socio-economic deprivation, with a high proportion of patients with underlying 
dementia.  Results may not be generalisable to other health care contexts. Due to the 
allocation of single sex wards within the GAU, our evaluation included a low proportion of 
male participants.  
Our data were gathered at a single point in time soon after admission and this may have 
artificially increased the diagnostic uncertainty of clinicians. In clinical practice patients 
are usually observed over a period, and this cumulative information ‘feeds in’ to 
determining whether or not delirium is present. Furthermore, while a small proportion of 
patients were identified as ‘too drowsy’ to be assessed for delirium, it may have been the 
case that these patients were ‘unassessable’ due to delirium. A revision to the DSM 5 
delirium diagnostic criteria states that reduced level of consciousness is fundamental and 
93 
 
patients must not be excluded due to not being able to complete direct cognitive testing 
[176]. 
I used ROC analyses to determine the optimal cut-points for the AMT-10 and AMT-4, due 
to the lack of existing research into optimal cut-points on these tests as screening tools 
for delirium. The approach may have exaggerated test performance compared to 
screening tests where a cut-point is already established (4AT, MOTYB).  
There is a need for further validation of the briefest screening tools in this evaluation, the 
AMT 4 and MOTYB, in the context of delirium screening to ensure they are able to 
identify individuals with delirium in a high number of cases. Future research would be 
valuable in validating and refining the scoring system of the 4AT as well as optimal cut-
points. Further validation of the evaluated index tests is essential across different clinical 
and geographical contexts is essential where-by differences in patient demographics may 
lead to different diagnostic test accuracy of the screening tools. 
Future research may also wish to explore the issue of clinician uncertainty in diagnosing 
delirium. While it is not the norm, it may be more appropriate for clinicians to have the 
option to provide a “possible delirium” diagnosis, rather than being forced to assign a 
definite yes or no delirium label.  
6.7 Conclusions 
The most brief, simple assessments in this study, the AMT-4 and MOTYB, were found to 
have good sensitivity for underlying delirium in a population with a high prevalence of 
underlying dementia. The 4AT was found to have a slightly lower sensitivity, but higher 
specificity than these more simplified screening tools. The bCAM had poor sensitivity for 
definite delirium within this study, although it was highly specific; it seems less suited as a 
screening tool than the other assessments. Finally, systematic gathering of informant 
information such as using the SQiD was shown to have potential as a screening test, 
however further work is required on ways to more to effectively capture this information. 
Overall, the 4AT would be recommended for use within this particular setting showing to 
be the most feasible tool for the screening of delirium with good sensitivity and 
specificity.
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Cognitive non-elective elderly care hospital inpatients 
n=500 
18 missed reference standard 
8 not assessable for reference 
standard 
AMT 10/AMT4       
n=422* 
MOTYB    
n=421* 
4AT                  
n=455* 
bCAM        
n=401* 
SQiD       
n=149* 
Too ill n=12                      
Severe Deafness n=10         
Too Drowsy n=18                   
Dysphasia n=9                       
Declined n=4                        
Severe Dementia n=20   
Missing Data n=5 
Too ill n= 12                               
Severe Deafness n=10                          
Too Drowsy n= 18                    
Dysphasia n=9                         
Declined n=6                                   
Severe Dementia n=20          
Missing Data n=4 
Nurse unable to provide 
information n=42                 
Missing data n=3 
Too ill n=10                                
Severe Deafness n=7                 
Too Drowsy n=13                        
Dysphasia n=8                                
Declined n=6                          
Severe Dementia n=17                  
Visual impairment n=1               
Nurse unable to provide 
information n=30                  
Missing data n=7 
No relative 
available/did not 
return form n=351 
Reference assessment DSM 5 delirium 
criteria complete 
n= 474 
Delirium   
n=93 
Possible   
n=104 
No delirium    
n=277 
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Figure 7 Flowchart illustrating the number of patients who received the DSM 5 delirium reference standard as well as numbers who 
completed each index test and reasons for those who did not. 
* The total number of patients who received each index test AND had a completed reference standard-  
AMT 10/AMT 4= 408; MOTYB= 406; 4AT= 434;  bCAM= 387; SQiD=141 
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Table 17 Summary of characteristics of patients by dementia diagnosis (DSM IV criteria). 
 All patients  
(n= 500)† 
Patients with 
prior dementia 
(n= 150) 
Patients with 
new dementia 
(n= 22) 
Patients with 
possible 
dementia 
(n= 94) 
Patients with 
no dementia 
(n= 208) 
Mean age (years) 83.1 (SD=6.7) 83.9 (SD=6.4) 84.8 (SD=6.5) 83.1 (SD=6.2) 82.6 (SD=7.1) 
Male n (%) 67 (13) 19 (12.7) 2 (9.1)  15 (16.0) 27 (13.0) 
Hearing impairment (%) 93 (18.6) 32 (21.3) 3 (13.6) 19 (20.2) 33 (15.9) 
Sight impairment (%) 139 (27.8) 36 (24.0)  3 (13.6) 28 (29.8) 63 (30.3) 
Alcohol dependence (%) 14 (2.8) 1 (0.7) 0 (0.0) 6 (6.4) 7 (3.4) 
Main symptom at presentation; 
Confusion only (%) 102 (20.4) 39 (26.0) 4 (18.2) 24 (25.5) 30 (14.4) 
Immobility only (%) 46 (9.2) 16 (10.7) 2 (9.1) 5 (5.3) 20 (9.6) 
Falls only (%) 104 (20.8) 26 (17.3) 4 (18.2) 18 (19.1) 53 (25.5) 
Combined confusion, 
mobility &/or immobility 
(%) 
99 (19.8) 27 (18.0) 11(7.3) 22 (23.4) 31 (14.9) 
Other (%) 149 (29.8) 42 (28.0) 1 (0.7) 25 (26.6) 74 (35.6) 
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Delirium diagnosis n (%) 93 (18.6) 30 (20.0) 5 (22.7) 41 (43.6) 17 (8.2) 
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Table 18 Mean scores split by delirium diagnosis with standard deviation in parenthesis 
(AMT 10, AMT 4, 4AT). 
 
 
 
Figure 8 Mean scores (AMT 10, AMT 4, MOTYB, 4AT) split by delirium diagnosis. 
Scoring: AMT 10, AMT 4 and MOTYB lower score equals greater impairment; 4AT higher score equals 
greater impairment.  
 
 Delirium  
(n=93) 
Possible delirium 
(n=104) 
No delirium  
(n=277) 
No diagnosis 
(n=18) 
AMT 10 3.4 (1.9) 4.7 (2.3) 6.5 (2.4) 5.4 (1.8) 
AMT 4 1.8 (1.1) 2.6 (1.1) 3.3 (1.1) 3.0 (1.2) 
MOTYB 1.5 (2.8) 3.3 (3.9) 6.7 (4.8) 4.7 (4.5) 
4AT  6.5 (2.4) 4.6 (3.0) 2.0 (2.5) 4.5 (4.0) 
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Table 19 Mean scores split by dementia diagnosis with standard deviation in 
parenthesis (AMT 10, AMT 4, 4AT). 
 New/Prior 
Dementia (n=172) 
Possible dementia 
(n=94) 
No dementia 
(n=208) 
No diagnosis 
(n=18) 
AMT 10 3.5 (2.2) 4.6 (2.0) 7.1 (2.0) 5.6 (1.9) 
AMT 4 1.9 (1.2) 2.5 (1.1) 3.6 (0.8) 3.1 (1.2) 
MOTYB 2.8 (3.7) 3.0 (3.9) 7.3 (4.7) 4.8 (4.5) 
4AT  5.0 (2.9) 5.1 (3.0) 1.4 (2.2) 4.3 (4.1) 
8 patients indicated as not to be assessed by senior clinician 
 
 
Figure 9 Mean scores (AMT 10, AMT 4, MOTYB, 4AT) split by dementia diagnosis. 
Scoring: AMT 10, AMT 4 and MOTYB lower score equals greater impairment; 4AT higher score equals 
greater impairment. 
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Table 20 Diagnostic test accuracy for delirium of the AMT-10, AMT-4, 4AT, bCAM, MOTYB and SQiD in study cohort of 500 patients. 
95% confidence intervals are presented in italics. Patients with a definite delirium diagnosis (n=93) classified as positive for delirium. 
 
 
 
 
 
 
 
 
 
 
 
 
 Area under the 
curve (AUC) 
Sensitivity % (n) 
 
Specificity % (n) Positive 
Predictive 
Value  % (n) 
Negative 
Predictive 
Value  % (n) 
AMT-10 
(score <4/10) 
n = 408 
0.80 86.6 (71/82) 
77.3-93.1 
63.5 (207/326) 
58.0-68.7 
37.4 (71/190) 
30.5-44.7 
95.0 (207/218) 
91.2-97.5 
AMT-4 
(score <3/4) 
n = 408 
0.80 92.7 (76/82) 
84.8-97.3 
53.7 (175/326) 
48.1-59.2 
33.5 (76/227) 
27.4-40.0 
96.7 (175/181) 
92.9-98.8 
4AT 
(score >4/12) 
n = 434 
0.84 86.7 (72/83) 
77.5-93.2 
69.5 (244/351) 
64.4-74.3 
40.2 (72/179) 
33.0-47.8 
95.7 (244/255) 
92.4-97.8 
bCAM 
n = 387 
 
0.81 70.3 (52/74) 
58.5-80.3 
91.4 (287/314) 
87.7-94.3 
65.8 (52/79) 
54.3-76.1 
92.9 (287/309) 
89.4-95.5 
MOTYB 
(score <5/12) 
n = 406 
0.76 91.3 (73/80) 
82.8-96.4 
49.7 (162/326) 
44.1-55.3 
30.8 (73/237)  
25.0-37.1 
 95.9 (162/169) 
91.7-98.3 
SQiD 
n = 141 
 
0.77 91.4 (32/35) 
76.9-98.2 
61.3 (65/106) 
51.4-70.6 
43.8 (32/73) 
32.2-56.0 
95.6 (65/68) 
87.6-99.1 
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Figure 10 ROC curves showing index test performance for patients with definite delirium compared to all other patients. 
Index tests illustrated are those which use a continuous scale- AMT 10, AMT 4, MOTYB and 4AT.
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Table 21 Diagnostic test accuracy for delirium of the AMT-10, AMT-4, MOTYB, 4AT, bCAM, and SQiD in study cohort of 500 patients. 
95% confidence intervals are presented in italics. Patients with a definite or possible delirium diagnosis (n=197) classified as positive for delirium. 
 
 
 
 
 
 
 
 Area under 
the curve 
(AUC) 
Sensitivity % (n) 
 
Specificity % (n) Positive 
Predictive 
Value % (n) 
Negative 
Predictive 
Value  % (n) 
AMT-10 
(score <4/10) 
n = 408 
0.78 76.4 (123/161) 
69.1-82.7 
72.9 (180/247) 
66.9-78.3 
64.7 (123/190) 
57.5-71.5 
82.6 (180/218) 
76.9-87.4 
AMT-4 
(score <3/4) 
n = 408 
0.77 85.1 (137/161) 
78.6-90.2 
63.6 (157/247) 
57.2-69.6 
60.4 (137/227) 
53.7-66.8 
86.7 (157/181) 
80.9-91.3 
4AT 
(score >4/12) 
n = 439 
0.83 69.8 (118/169) 
63.6-77.9 
76.7 (207/270) 
71.8-82.1 
69.8  (118/169) 
62.3-76.6 
81.2 (207/255)  
75.8-85.8 
bCAM 
n = 387 
 
0.70 45.6 (67/147) 
37.4-54.0 
95.0 (228/240) 
91.4-97.4 
84.8 (67/79) 
75.0-92.0 
74.0 (228/308) 
68.8-78.8 
MOTYB 
(score <5/12) 
n = 406 
0.75 82.4 (131/159) 
75.6-88.0 
61.5 (152/247) 
55.2-67.6 
58.0 (131/226) 
51.2-64.5 
84.4 (152/180) 
78.3-89.4 
SQiD 
n=141 
 
0.68 71.0 (49/69) 
58.8-81.3 
66.7 (48/72) 
54.6-77.3 
67.1 (49/73) 
51.2-64.5 
70.6 (48/68) 
78.3-89.4 
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Table 22  4AT diagnostic test accuracy of individual items.  
 N* AUC Sensitivity (%) Specificity (%) PPV (%) NPV (%) 
Altered alertness  
 
476 0.55 14.4 (13/90) 
95% CI= 7.9-
23.4 
95.3 (368/386) 
95% CI= 92.7-
97.2 
41.9 (13/31) 
95% CI= 24.6-
60.9 
82.7 (368/445) 
95% CI= 78.9-
86.1 
AMT 4 1 incorrect  
477 
 
0.74 
93.4 (85/91) 
95% CI= 86.2-
97.5 
45.1 (174/386) 
95% CI= 40.0-
50.2 
28.6 (85/297) 
95% CI= 23.6-
34.1 
96.7 (174/180) 
95% CI= 92.9-
98.8 
2 or more 
incorrect 
78.0 (71/91) 
95% CI=68.1-
86.0 
65.0 (251/386) 
95% CI= 60.0-
69.8 
34.5 (71/206) 
95% CI=28.0-
41.4 
92.62 
(251/271) 
95% CI= 88.8-
95.4 
MOTYB (<7) 476 0.63 94.4 (85/90) 
95% CI= 87.5-
98.2 
39.6 (153/386) 
95% CI= 34.7-
44.7 
26.7 (85/318) 
95% CI= 22.0-
32.0 
96.8 (153/158) 
95% CI= 92.8-
99.0 
Acute 
change/fluctuating 
course 
436 0.80 82.9 (68/82) 
95% CI= 73.0-
90.3 
77.1 (273/354) 
95% CI= 72.4-
8.4 
45.6 (68/149) 
95% CI= 37.5-
54.0 
95.1 (273/287) 
95% CI= 92.0-
97.3 
*N represents number of patients this item of the 4AT was able to be completed in. 
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Table 23 Frequencies of ‘don’t know’ responses for patients with ‘possible delirium’ (n=104). As assessed by clinicians on separate 
components of the DSM-V delirium criteria. 
 
 
DSM V 
item 
Altered 
attention 
Altered 
awareness 
Acute onset Change from 
baseline 
Fluctuation Addition 
disturbance 
in cognition 
Better 
explained by 
pre-existing 
disorder 
Occurs 
during coma 
Evidence of 
physiological 
cause 
All 
patients 
5/104  
(4.8%) 
11/104 
(10.6%) 
56/104 
(53.8%) 
65/104 
(62.5%) 
57/104 
(54.8%) 
13/104 
(12.5%) 
51/104 
(49.0%) 
3/104 
(2.9%) 
0/10 
(0%) 
Dementia 
new/prior 
3/57 
(5.3%) 
4/57 
(7.0%) 
32/57 
(56.1%) 
38/57 
(66.7%) 
32/57 
(56.1%) 
2/52 
(3.8%) 
29/52 
(55.8%) 
1/52 
(1.9%) 
0/52 
(0%) 
 
Possible 
Dementia 
1/41 
(2.4%) 
7/41 
(17.1%) 
22/41 
(53.7%) 
25/41 
(61.0%) 
24/41 
(58.5%) 
10/41 
(24.4%) 
22/41 
(53.7%) 
2/41 
(4.9%) 
0/41 
(0%) 
No 
Dementia 
1/6 
(16.7%) 
0/6 
(0%) 
2/6 
(33.3%) 
2/6 
(33.3%) 
1/6 
(16.7%) 
1/6 
(16.7%) 
1/6 
(16.7%) 
0/6 
(0%) 
0/6 
(0%) 
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Chapter 7: Discussion 
 
7.1 General discussion 
7.1.1 Current practice of assessment of cognitive impairment and delirium 
Delirium can easily go undetected, especially in elderly individuals with a variety of 
physical and psychological issues. It is also a prevalent problem with a range of associated 
negative outcomes for the patient. In this thesis I have evaluated the current evidence 
base as well as clinical practice of screening for possible cognitive impairment and 
delirium, with a focus on older hospitalised patients in the acute care setting. Informed 
by these findings, an evaluation of delirium screening tools in acute care was carried out. 
I was particularly interested in determining how these screening tools would perform 
against a gold standard clinician diagnosis in a representative, consecutive patient cohort. 
This chapter will discuss the principle findings presented in this thesis in the context of 
existing clinical guidelines and literature as well how this body of work adds to our 
understanding of delirium assessment within acute care. Strengths and limitations of 
methodology will also be discussed as well as how implications of these findings can be 
expanded in future research.  
The aims of this PhD thesis were; 
i) To examine the performance of very brief screening tools in previously 
examined cohorts within acute care as well as other healthcare settings. 
ii) To determine current practice of delirium and cognitive impairment screening 
locally and Scotland-wide within acute care. 
iii) To examine the diagnostic test accuracy of delirium screening tools 
recommended for routine use within the acute care setting. 
iv) To evaluate the feasibility of these delirium screening tools within the acute 
care setting. 
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The overall aim was to provide evidence that could inform current clinical practice of 
cognitive impairment screening. A summary of the projects explored in this thesis is 
presented in Table 24. 
In chapters 2 and 3, I aimed to establish if very brief, single questions can reliably identify 
possible cognitive impairment across all healthcare settings. I did this by carrying out a 
systematic review of all single screening questions for cognitive impairment as well as 
secondary data analysis on a data set which employed 2 single screening questions in the 
acute care setting. I was also interested in establishing if there was further scope for 
research of single screening questions for cognitive impairment. 
Chapter 2 adds to the existing literature a timely review in to single question screening 
for cognitive impairment including delirium. The systematic review revealed 
heterogeneity in the single questions used aimed at the screening of delirium, dementia 
and/or MCI, with a lack of validation for any specific question. Despite the lack of 
evidence, this systematic review was carried out at a time when a single screening 
question approach was being rolled out across England and Wales as part of a paid 
government initiative [111].  Furthermore, there is no evidence in the literature to 
suggest that the question used in this initiative is effective. Thus, a non-evidence-based 
approach to clinical practice is being used with no validation data to support it. It has 
been demonstrated that evidence-based practice is associated with higher quality of care 
and better outcomes for patients across healthcare settings, compared to methods based 
on tradition [184].  
In chapter 4 and 5, the focus was on current practice in Scotland in relation to screening 
for cognitive impairment. A service evaluation in a large general hospital as well as survey 
of lead clinicians within acute care wards across Scotland was undertaken. The 
nationwide survey revealed that a variety of tools for examining for cognitive impairment 
were used across the country, with evidence that locally developed tools for delirium 
were preferred in the East of Scotland and little was done to screen for delirium in the 
West. This lack of general consensus for screening of cognitive impairment across 
Scotland suggests a lack of evidence-based practice. Guidelines published by HIS [88] 
suggest that a ‘local tool’ should be used for the screening of delirium within the delirium 
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management pathway, with no further elaboration on the meaning of ‘local tool’. This is 
recommended rather than suggesting tools which have a well-established base of 
evidence for the detection of possible delirium. These guidelines also recommend routine 
cognitive assessment although do not recommend one tool to do this but rather give 
examples of a range of possible tools.   
The lack of uniform screening for cognitive impairment and delirium also limits future 
research abilities to compare and contrast across different acute care cohorts, with 
different scoring systems on different tests being difficult to compare. Thus, limiting our 
ability to fully evaluate screening test performance and how improvements to care of 
patients with delirium and dementia can be implemented.   
It is important to carry out screening of delirium and not doing this or using clinician 
judgement alone may have severe consequences for patients. Results from the clinician 
survey suggesting that little was done to screen for delirium in the West of Scotland were 
further enforced by service evaluation results which showed that while initial, brief 
assessment of cognitive assessment was carried out relatively well using the AMT 4 [180], 
there was no record of screening tools for delirium. This may suggest that there is a lack 
of awareness of the importance of delirium detection in this region.  
In chapter 6 I wanted to further explore the outcomes of previous chapters which 
revealed that locally there was a problem in that not much was being done to screen for 
delirium. This is in spite of existing UK guidelines which recommend that all patients age 
65 and over should be screened for delirium [160]. Due to the large number of delirium 
and cognitive impairment screening tools available, I decided to evaluate only those 
which were currently recommended for routine clinical use. The data I collected from 500 
consecutive acute care in-patients revealed that the AMT 4 and 4AT are sensitive tools 
for the detection of possible delirium and are feasible for use within the acute care 
setting. MOTYB, executed as a component of two of the recommended tools, also stood 
out as showing promise for use as a standalone screen for delirium screening. Further 
investigation is needed to establish how best to capture informant response in a more 
feasible way, as the limited responses I was able to capture showed high sensitivity.  
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7.1.2 Clinical implications for delirium screening  
Scottish and UK guidelines are in agreement that delirium is an important priority which 
should be routinely assessed in clinical practice. However, guidelines in the UK such as 
those published by HIS, the Scottish Delirium Association and NICE [160] appear vague or 
lack an evidence-based approach in their recommendations of delirium screening tools. 
This thesis provides an overview of clinical practice across Scotland and also provides 
clinical evaluation of screening tools for delirium which may better inform guidelines of 
which tools are feasible and sensitive in the screening of delirium. 
The systematic review carried out in chapter 2 was motivated by a routine single 
screening question for cognitive impairment being rolled out nationally across England 
and Wales. I hypothesised that there would be a lack of strong, comparable evidence to 
support the use of a single screening question for acute and/or chronic cognitive 
impairment across healthcare settings. This hypothesis was supported by the review 
which found that there were few studies of single screening questions available with 
considerable heterogeneity. This review calls for validation of the CQUIN single question 
to assess if it is a suitable way to screen for cognitive impairment on a national basis, due 
to the lack of existing evidence to support this approach.  
While it is not clear if the use of a single screening question for the first step in detection 
of possible cognitive impairment is ideal, the use of a uniform assessment method 
nationally has potential benefits. Chapter 4 revealed that there was no clear consensus 
on which tests to use to screen for cognitive impairment and delirium across Scottish 
acute care settings. Wide variation in cognitive assessment method use poses difficulties 
for description and comparison of these across diverse older patient cohorts. This lack of 
ability to compare patient assessments across different hospitals limits the ability of 
research to establish the true impact of delirium on long-term outcomes such as 
functional impairment, chronic cognitive impairment and mortality. The implementation 
of a Scotland or UK wide delirium and cognitive assessment pathway may offer benefits 
to both patients and clinicians. In chapter 6 I established that there are effective 
screening tools for delirium available which are brief, feasible and have high sensitivity in 
the acute care setting with patients over 65.  
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Results from the evaluation detailed in chapter 6 fed in to local West of Scotland 
guidelines for screening of delirium in acute care by providing recommendation accurate 
and feasible screening methods directly to a local clinical governance group, the Delirium 
Short Life Working group. However, a limitation of this investigation is that no follow-up 
was carried out to assess the outcome of these findings. The desired outcome would be 
that common assessment tool(s) were adopted across the West of Scotland and used 
routinely for the detection of possible delirium in acute care wards with all patients. 
Future evaluation of this may be of interest to establish if an evidence-based clinical 
practice approach was adopted.  
The study described in chapter 6 reports the feasibility and test accuracy of a range of 
tools designed for the assessment of cognitive impairment and/or delirium. This was an 
evaluation of tools recommended for routine clinical use in Scotland. However, as already 
established, existing guidelines do not necessarily base recommendations on the best 
tools to use according to existing research. Thus, there may be more suitable validated 
screening tools available than those evaluated in chapter 6. A recent systematic review of 
delirium assessment in hospitalised patients revealed a range of screening tools which 
were not evaluated in this study [185] including the Nursing Delirium Screening Scale 
[186] and the Delirium Rating Scale [187] which both showed good sensitivity and 
specificity. 
 
7.1.3 Suggestions for future research 
The data presented in this thesis provide logical basis for further investigations within this 
research area including the utility of single question screening for both acute and chronic 
cognitive impairment. While it was revealed in chapter 2 that research in the area of 
single question cognitive screening is lacking, this does not discount the potential use of 
this very brief method of assessment and further research in representative patient 
cohorts would be highly beneficial.  
In chapter 6 I provided diagnostic test accuracy data for the AMT and MOTYB which are 
tools not originally designed for the screening of delirium. Future research may be useful 
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to validate a cut-off point for the use of the AMT. Further validation of MOTYB in the 
acute care setting is also necessary.  
For the patient assessment component of this thesis, I did attempt to be as inclusive as 
possible by selecting a consecutive cohort of older, acute in-patient. This cohort is suited 
to an evaluation of recommended routine delirium assessments.  However, this sample 
may not be representative of all patients in acute hospital environments. Patients were 
recruited from a central Glasgow hospital; an area of lower socio-economic status 
compared to the rest of Scotland with half of Glaswegians living in 20% of Scotland’s most 
deprived areas [188]. Lower socio-economic status has been found to be associated with 
higher incidence of dementia [189]. While the relationship between socio-economic 
status and delirium is unclear, dementia is a known risk factor of delirium. Audit data 
from an Australian hospital failed to reveal an association between delirium and socio-
economic status [190]. However, it may be especially important to assess for cognitive 
impairment in areas with greater deprivation. Future research could further explore this 
relationship between socio-economic status and delirium, specifically in the UK.  
It is essential that screening tools for delirium are also suitable for use with patients with 
dementia. In our cohort, a third of patients had dementia and over half of patients with 
dementia were diagnosed as having either definite or possible delirium. This highlights 
that dementia is very common in this population and increases the risk of a possible 
delirium. While I felt that it was out with the scope of this data, test accuracy of delirium 
assessment tools as a function of underlying dementia would be an area of interest for 
further exploration. 
It is important to note that identification and implementation of effective delirium 
screening tools are different matters. Delirium education aimed at all clinicians 
responsible for older patients may be as essential as validation of the screening tools to 
be used. Research examining the use of educational interventions in relation to delirium 
has shown promising results. To investigate this, researchers carried out an audit before 
and after intervention implementing two 30 minute delirium ward-based education 
classes per month as well as one hour long departmental lessons. These educational 
sessions were based on information from the NICE delirium workshop session guide [180]. 
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Following intervention, 35% of patients received a delirium diagnosis using the Confusion 
Assessment Method (CAM) [16]. Prior to educational intervention to increase awareness 
of delirium, only 5.7% of patients received a delirium diagnosis. This has clinical 
implications for geographical areas identified as under-recognising delirium. National 
policy could allow for a standardised form of educational intervention to create a better 
awareness of the importance of delirium among clinicians. However, further research is 
needed to establish whether educational intervention provides a lasting or temporary 
effect on delirium detection.  
Future research should focus on the evaluation of a full delirium assessment and 
treatment pathway, based on existing research, and evaluation this alongside usual 
practice. Validation of a standardised procedure for the screening and treatment of 
delirium in a large, representative older in-patient cohort would allow for 
implementation in to clinical practice. This would also require the use of a comprehensive 
training and education program for clinical staff. 
 
7.2 Conclusions 
The chapters in this thesis have investigated the use of delirium and cognitive impairment 
assessment tools, with particular interest in older acute hospital in-patients. It was 
highlighted that there was a lack of consensus in the screening tools being used, with a 
poor research base for ultra-brief cognitive screening tools and lack of evidence-based 
clinical practice being implemented in Scotland. I found a particular problem with little 
being done to formally screen for delirium within the West of Scotland.  
While NICE acknowledge that clinical practice for the assessment of delirium and 
dementia should be informed by a combination of clinician expertise and research, 
currently this balance does not seem to have been achieved. Clinical practice should 
always reflect existing research evidence to improve patient care and outcomes by 
executing ‘tried and tested’ methods in high quality research.  The study described in 
chapter 6 empirically evaluated cognitive assessments for the detection of possible 
delirium which could contribute to inform current guidelines.  
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 Screening for delirium in older, unscheduled hospital admissions is a highly important 
area of research which may hold particular benefits for the long-term outcomes of these 
patients. Furthermore, screening may be considered the first step in any intervention of a 
given disorder. However, for screening to have any utility, a documented pathway is 
essential to illustrate the assessment, diagnosis and treatment of delirium based on 
existing evidence.  
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Table 24 Summary of the main findings presented in this thesis and how thesis aims were executed across the chapters. 
Thesis aim Studies 
(chapters)  
Hypothesis Outcomes 
To examine the performance of 
very brief screening tools in 
previously examined cohorts 
within acute care as well as other 
healthcare settings. 
 
Systematic 
review & 
secondary 
data analysis 
(2 & 3) 
• The existing evidence base for very 
brief cognitive screening tools (single 
screening questions) would be 
limited. 
• Very brief cognitive screening tools 
(single screening questions) would 
show promise in the acute care 
setting. 
• Only 5 studies utilising single screening questions 
for dementia/MCI/delirium identified by 
systematic review. 
• Secondary data analysis in acute care showed 
good sensitivity and specificity of a single 
screening question for dementia but lower 
sensitivity and specificity for a separate single 
screening question for delirium. 
To determine current practice of 
delirium and cognitive 
impairment screening locally and 
Scotland-wide within acute care. 
 
Service 
evaluation & 
clinician 
survey (4 & 5) 
• Screening for cognitive impairment 
would be carried out routinely and 
the tools used would show variation 
through-out Scotland. 
• Screening tools specifically for 
delirium would be executed less well 
than screening for general cognitive 
impairment. 
• Local service revealed screening for cognitive 
impairment was carried out relatively well using 
a recommended brief screening tool (AMT 4). 
• Local service evaluation and national survey 
revealed delirium screening was carried out less 
well, particularly in the West of Scotland. 
• There was heterogeneity in screening tools used 
for cognitive impairment and delirium across 
Scotland. 
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To examine the diagnostic test 
accuracy of delirium screening 
tools recommended for routine 
use within the acute care setting. 
 
Delirium 
screening tool 
evaluation (6) 
• Screening tools recommended for 
routine clinical use would show good 
diagnostic test accuracy for delirium 
within the acute care setting. 
• Most of the screening tools evaluated showed 
good sensitivity. 
• The AMT 4, MOTYB and SQiD showed excellent 
sensitivity at the expense of specificity. 
• The bCAM did not appear to be suitable for use 
within the acute care setting, showing excellent 
specificity at the cost of sensitivity.  
To evaluate the feasibility of 
these delirium screening tools 
within the acute care setting. 
 
Delirium 
screening tool 
evaluation (6) 
• The screening tools evaluated would 
be feasible for the screening of 
delirium within the acute care 
setting. 
• The 4AT showed the best feasibility in this 
evaluation.  
• The AMT 4/10 and MOTYB also showed good 
feasibility with patients in acute care. 
• The SQiD was not found to be feasible in this 
evaluation, being returned by relatives in less 
than a third of patients. 
MCI = Mild cognitive impairment, AMT=Abbreviated Mental Test, MOTYB=Months of the year backwards, SQiD=Single question in delirium, 4AT=4 A’s Test
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Appendices. 
Appendix A. Search strategies 
Cochrane DTA search terms 
• (“informant* questionnaire*” adj3 (dement* or screening)).ti,ab 
• “informant questionnaire on cognitive decline in the elderly ”.ti,ab 
• (“screening test*” adj2 (dement* or alzheimer*)).ti,ab. 
• “inform* interview”.ti,ab. 
• “brief alzheimer* screen”.ti,ab. 
• “brief cognitive scale”.ti,ab. 
• “community screening interview for dementia”.ti,ab. 
• “cognitive abilities screening instrument”.ti,ab. 
• “cognitive assessment screening test”.ti,ab. 
• “cognitive capacity screening examination”.ti,ab. 
• “deterioration cognitive observee”.ti,ab. 
• “memory impairment screen”.ti,ab. 
• “quick cognitive screening test”.ti,ab. 
• “rapid dementia screening test”.ti,ab. 
• “short cognitive performance test”.ti,ab. 
• “short test of mental status”.ti,ab. 
• “dementia questionnaire”.ti,ab. 
 
• exp Dementia/ 
• Delirium, Dementia, Amnestic, Cognitive Disorders/ 
• dement*.ti,ab. 
• alzheimer*.ti,ab. 
• AD.ti,ab. 
• “cognit* impair*”.ti,ab. 
• (cognit* adj4 (disorder* or declin* or fail* or function*)).ti,ab 
• (memory adj3 (complain* or declin* or function*)).ti,ab. 
• Memory Disorders/di 
 
• exp “sensitivity and specificity”/ 
• sensitivit*.ab. 
• specificit*.ab. 
• (ROC or “receiver operat*”).ab. 
• Area under curve/ 
• (“Area under curve” or AUC).ab. 
 
Web of Knowledge  (edited compatible search strategy) 
• (“ informant* questionnaire”  (dement* or screening)) 
• ((“screening test*” (dement* or alzheimer*))) 
•  “inform* interview” 
• “brief alzheimer* screen” 
• “brief cognitive scale” 
• “community screening interview for dementia” 
• “cognitive abilities screening instrument” 
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• “cognitive assessment screening test” 
• “cognitive capacity screening examination” 
• “deterioration cognitive observee” 
• “memory impairment screen” 
• “quick cognitive screening test” 
• “rapid dementia screening test” 
• “short cognitive performance test” 
• “short test of mental status” 
• “dementia questionnaire” 
 
 
• exp Dementia/ 
• Delirium, Dementia, Amnestic, Cognitive Disorders/ 
• dement* 
• alzheimer* 
• AD 
• “cognit* impair*” 
• (cognit* (disorder* or declin* or fail* or function*)) 
• (memory (complain* or declin* or function*)) 
• Memory Disorders/ 
 
• exp “sensitivity and specificity”/ 
• sensitivit* 
• specificit* 
• (ROC or “receiver operat*”) 
• Area under curve/ 
• (“Area under curve” or AUC) 
 
EBSCO search strategy (PsychInfo & CINAHL) 
((“informant*  questionnaire” (dement* screening)) *use SmartText Searching* 
((“screening test*” (dement* alzheimer*))) *use SmartText Searching*  
 “inform* interview” 
“brief alzheimer* screen” 
“brief cognitive scale” 
“community screening interview for dementia” 
“cognitive abilities screening instrument” 
“cognitive assessment screening test” 
“cognitive capacity screening examination” 
“deterioration cognitive observee”   *use Smart Text Searching* 
“memory impairment screen” 
“quick cognitive screening test” 
“rapid dementia screening test” 
“short cognitive performance test” 
“short test of mental status” 
“dementia questionnaire” 
 
-AND- 
 
DEMENTIA 
exp Dementia/ 
Delirium, Dementia, Amnestic, Cognitive Disorders/ 
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dement* 
alzheimer* 
AD 
“cognit* impair*” 
(cognit* (disorder* declin* fail* function*)) *use SmartText Searching* 
(memory (complain* declin* function*))  *use SmartText Searching* 
Memory Disorders/  
 
DELIRIUM 
 
Delirium 
Acute Confusion* 
 
MCI 
MCI  
“Mild cognitive impairment” 
CIND 
“Cognitive impairment no dementia” 
 
 
 
 
-AND- 
exp “sensitivity specificity”/  *use Smart Text Searching* 
sensitivit* 
specificit* 
(ROC “receiver operat*”) 
Area under curve/ 
(“Area under curve” AUC) 
 
-AND- 
 
1 item 
1 item screen 
Single question screen 
Single screening qu*  
Single qu* detection 
Single item screen 
SQiD 
Single qu* in delirium 
Single item 
Item analysis 
Qu* analysis 
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Appendix B. Target journal articles.  
 
Ayalon, L. (2011). The IQCODE versus a single-item informant measure to 
discriminate between cognitively intact individuals and individuals with 
dementia or cognitive impairment. Journal of Geriatric Psychiatry & Neurology, 
24(3), 168-173. 
 
Chong, M.S., Chin, J.J., Saw, S.M., Chan, S.P., Venketsasubramanian, N., Tan, L.C.S., et al. 
(2006). Screening for dementia in the older Chinese with a single question test 
on progressive forgetfulness. International Journal of Geriatric Psychiatry, 21, 
442-448. 
 
Ekerstrom, M., Skoogh, J., Rolstadh, S., et al. (2013). Sahlgrenska academy self-
reported cognitive impairment questionnaire (SASCI-Q) – a research tool 
discriminating between subjectively cognitively impaired patients and healthy 
controls. International Psychogeriatrics, 25, 420-430. 
 
Li, M., Ng, T.P., Kua, E.H., & Ko, S.M. (2006). Brief informant screening test for mild 
cognitive impairment and early Alzheimer’s disease. Dementia and Geriatric 
Cognitive Disorders, 25, 392-402. 
 
Sands, M.B., Dantoc, B.P., Hartshorn, A., Ryan, C.J., & Lujic, S. (2010). Single question in 
delirium (SQiD): testing its efficacy against psychiatrist interview, the 
Confusion Assessment Method and the Memorial Delirium Assessment Scale. 
Palliative Medicine, 24(6), 561-565.
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Appendix C. Information for extraction to pro-forma. 
 
A. Bibliographic information from paper 
- Author, paper title, journal title, year of publication, issue and page 
number(s).  
B. Index test information 
- Index test question. 
- Who administered.  
- Respondent. 
- Response method e.g. dichotomised, likert scale. 
- Type of cognitive impairment assessed e.g. delirium, dementia, MCI. 
- Proportion screened positive and negative for cognitive impairment. 
C. Reference standard 
- Reference standard used. 
- Who administered. 
- Type of cognitive impairment assessed e.g. delirium, dementia, MCI. 
- Proportion positive and negative for cognitive impairment.  
D. Study population 
- Number of participants. 
- Age. 
- Gender. 
- Country study conducted in. 
- Setting e.g. primary care, secondary care, community. 
- Sampling type. 
- Time between index test and reference standard. 
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Appendix D. TIME delirium acute care bundle. 
Initiate T,I & M within 2 hours 
(include initials & time when complete) 
Assessed/Seen Results Seen Abnormality found 
 
 
T 
Think, exclude and treat possible triggers 
NEWS (think Sepsis Six)    
Blood Glucose    
Medication History 
(new/changes/recently 
stopped) 
   
Pain Review (Abbey Pain 
Scale) 
   
Assess for urinary retention    
Assess for Constipation    
 
I 
Investigate and intervene to correct underlying causes 
Assess hydration and start 
fluid balance chart 
   
Bloods    
Look for symptoms/signs of 
infection & perform 
appropriate cultures/imaging 
depending on clinical 
assessment 
   
ECG    
 
M 
Management plan Completed 
Initiate treatment of all underlying causes found above  
 
E 
Engage & explore (within 2 hours or within 24 if family not present)  
Engage with family/carer- establish if this is normal behaviour. 
Ask; “how would you like to be involved?” 
 
Explain diagnosis of delirium to patient/family or carers  
Document diagnosis of delirium  
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Appendix E. Data collection sheet used during service evaluation of older patient wards at Glasgow 
Royal Infirmary. 
      Key:
Age 
(yrs) 
Sex 
(m/f) 
Usual 
place of 
residenc
e 
Dischar
ge 
destinat
ion 
Date of 
admissi
on 
Date of 
discharge
/death 
Cognitive assessments  
(date) 
 
Delirium 
(y/n/not 
stated) 
Method of 
diagnosis (if 
recorded) 
Other suggestion 
of poss. CI 
Known 
dementia 
diagnosis 
(y/n) 
Barriers to 
cognitive 
assessment 
            
            
            
            
            
            
            
Usual place of residence  
1) home 2)sheltered/supp accom      
3) residential/nursing care 4) NHS 
LTC 5) other (specify) 
Discharge destination 
1) home 2)sheltered/supp accom      
3) residential/nursing care 4) NHS 
LTC 5) death 6) other (specify) 
Barriers to cognitive assessment 
1) hearing imp. 2) sight imp.  3) 
dysphasia 4) unwilling  5) too 
drowsy/LOC 7) too unwell/dying 6) 
other (specify) 
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Appendix F. Clinician survey of usual clinical practice.  
Survey of usual clinical practice 
1. Please give the name and location of the hospital you are based in 
 
 
 
 
2. Does your unit have set guidelines for the practice of screening for 
cognitive impairment in older hospital inpatients (> 65 years)? (please 
highlight) 
Yes    No 
 
3. What tool(s) is/are primarily used for the screening of mild cognitive 
impairment and dementia in older hospital inpatients?  
 
 
 
4. What tool(s) is/are primarily used for the assessment of delirium in older 
hospital inpatients? (if any) 
 
 
 
5. How well do you think screening for cognitive impairment is carried out 
within your unit? (please highlight) 
1 ______________ 2 ______________ 3 ______________ 4______________ 5 
 Not at all well         Extremely well 
Thank you very much for your help. Please return to kirsty.hendry0@gmail.com 
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Appendix G. Caldicott Guardian Approval Form 
Application for Caldicott Guardian Approval  
 
 
NOTE:  You must address the 6 Caldicott principles (Appendix A) when 
submitting this application. 
 
1.  Study / Project Title 
The diagnostic accuracy of recommended delirium screening tools within geriatric 
medical in-patients 
 
 
 
2. Please tick the type of study/project you are undertaking 
Audit   □      Research   √□    Service Improvement   √□      Other    □ 
If other, please provide further details: 
 
 
 
3.  Who is providing clinical support for the study / project 
Name: Prof David J Stott 
Designation: Professor of Geriatric Medicine and Honorary NHS Consultant, Glasgow 
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Royal Infirmary 
Email Address or Telephone Number: david.j.stott@glasgow.ac.uk;  
 
 
4.  Details of individual / organisation requesting data   
Name: Prof David J Stott 
Designation: Professor of Geriatric Medicine and Honorary NHS Consultant 
Work/University Address: 
Room 2.04, Floor 2, New Lister Building, Glasgow Royal Infirmary G31 2ER 
 
 
Contact Number: tel 0141 201 8510 
 
 
 
5.  Purpose for which data are to be used (Principle 1) 
 
Accurate recognition of delirium in older people in hospital is a current NHS 
priority. 
Departments of Medicine for Older People in NHS GG&C aim to assess all 
patients for delirium, indeed cognitive assessment is an audit standard for external 
assessors such as OPAC.  
 
We propose an evaluation of standard screening tests for cognitive impairment; 
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however given that there is variation in current practice the project will involve a 
clinical researcher (KH) applying these tests in a consistent and systematic 
manner.  
 
 
The clinical diagnosis "gold standard" is recorded as part of routine clinical care 
and does not require additional testing.  
 
It is currently unclear what clinicians should do as a first step in identification of 
delirium. This project will evaluate brief cognitive assessments (patient 
questionnaire comprising a total of 17 short items) that have been recommended 
for routine clinical practice; these items are included in the brief Confusion 
Assessment Method (bCAM), the 10-point Abbreviated Mental Test (AMT-10), 
4’A’sTest (4AT) and the single question recommended in England and Wales as 
part of the Commissioning for Quality and Innovation (CQUIN) program (Have you 
been more forgetful in the last 12 months to the extent that it has significantly 
affected your daily life?). This information takes between 5 and 10 minutes to 
gather.  
 
The following data will be recorded from the patient case record or informant 
interview (carer, relative or friend; or nurse) - 
a) Has the patient’s mental status changed from baseline?  
b) Has the patient’s mental status fluctuated since admission?  
c) What is the patient’s current mental status? (coded as per the Richmond 
Agitation Sedation Scale - RASS) (informant - nurse). 
d) CQUIN question (informant – carer, relative or friend). 
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The feasibility within a non-elective elderly-care hospital in-patient cohort of 
gathering the component information for these assessment tools will be 
determined, and diagnostic accuracy of these tools (sensitivity, specificity, positive 
predictive values and negative predictive values) will be compared against a 
reference standard of experienced clinician (geriatrician and / or 
psychogeriatrician) evaluation based on the DSM 5 diagnostic criteria for delirium.  
 
The information gathered by KH for the index test scores will be shared with the 
clinician who carried out the reference standard clinical assessment of delirium 
once all assessments are complete. Therefore all information gathered will be 
used as part of the clinical process.   
 
 
6.  Which identifiable data items are required?  Please detail why these are 
required.    (Principles 2 and 3) 
PID Required √ Justification 
CHI Number 
 
No  
 
 
Forename 
 
No  
 
 
Surname 
 
No  
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DOB 
 
No  
 
 
Age 
 
√ To allow basic description of population 
studied 
 
 
Gender 
 
√ To allow basic description of population 
studied 
 
 
Address 
 
No  
 
 
Post code (full) 
 
No  
 
 
Post code (partial) 
 
No  
 
 
Clinical data 
 
√ 1) Clinical records: 
Case notes documentation of acute 
confusion, fluctuation, prior dementia (also 
portal). Also may be obtained by nurse / carer 
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or relative interview. 
2) single question to relative / carer of 
forgetfulness as recommended for routine use 
in CQUIN England. 
2) Patient assessment - recommended 
routine assessments to be performed by 
researcher (KH): 
AMT10, spell lunch backwards, give months 
of year backwards, 4 questions for 
disorganised thinking, single question to 
patient on cognitive decline in last 12 months 
(from CQUIN as  above). 
3) Expert clinician (geriatrician and / or 
psychogeriatrician) diagnosis of delirium and 
or dementia. 
 
Other (please specify) 
 
No  
 
 
 
7.  Who will have access to this information?  (Principle 4) 
Internal: Kirsty Hendry, Prof D J Stott 
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External: No 
 
 
 
 
 
 
 
8.  Storage and use of personal data during the audit/project (Principle 5) 
Will you be undertaking any of the following activities at any stage (including the 
identification of potential participants)?  Please tick as appropriate. 
 
  √□      Access to Health Record (paper) 
  √□      Access to Health Record (electronic) 
  □      Sharing of identifiable data with other organisations (provide further detail 
below) 
  √□      Publication of data (if this could identify individuals provide further detail 
below) 
  □      Use of audio/visual recording devices 
   □      Storage of personal identifiable data on any of the following: 
             □      Manual files, including x-rays 
             □      NHS Computers 
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             □      Home or other personal computers 
             □      University computer 
             □      Private company computer 
             □      Laptop computer (or any other mobile device) 
             □      USB Flash Drive 
 
Additional Information: 
Non-identifiable information (age, gender, cognitive assessments, diagnoses of 
delirium and dementia) will be stored in a password protected file on a password 
protected university desktop computer, in a locked room (2.03 New Lister 
Building), backed up on the University secure server. 
Paper record forms will be used to collate data prior to entry on the computer file. 
These will be kept in a locked cabinet in room 2.03 New Lister Building and 
destroyed (confidential waste) after data entry. 
 
 
 
 
 
 
9.  Destruction of Data 
How long will the data be held? 10 years 
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How will the data be destroyed? Deletion from desktop computer and from 
University server. 
 
 
10.  Please provide your organisation’s Data Protection Registration Number (if 
external to NHSGGC) 
 
Not applicable 
 
 
Note:   
 Copies of any other relevant supporting documentation (e.g. ethics approval, 
patient information leaflet etc.) should be attached to this application 
 Appendix A details the Caldicott Principles 
 
 
Person responsible for the requested data 
 
Name ……………David J Stott………………………………………. 
 
 
Designation  ……Professor of Geriatric Medicine and Honorary NHS Consultant, 
GRI… 
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Signature: …… ……………… 
Date:……13th March 2014……….. 
 
 
 
 
The release of data as described above is:   approved  /  not approved 
 
 
Caldicott Guardian ……………………………………      
Date ……………………………. 
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Caldicott principles 
        
Principle 1 - Justify the purpose(s)  
Every proposed use or transfer of patient-identifiable information within or from an 
organisation should be clearly defined and scrutinised, with continuing uses 
regularly reviewed, by an appropriate guardian. 
 
Principle 2 - Don't use patient-identifiable information unless it is absolutely 
necessary 
Patient-identifiable information items should not be used unless there is no 
alternative. 
 
Principle 3 - Use the minimum necessary patient-identifiable information 
Where use of patient-identifiable information is considered to be essential, each 
individual item of information should be justified with the aim of reducing 
identifiability. 
 
Principle 4 - Access to patient-identifiable information should be on a strict 
need-to-know basis 
Only those individuals who need access to patient-identifiable information should 
have access to it, and they should only have access to the information items that 
they need to see.  
 
Principle 5 - Everyone should be aware of their responsibilities 
Action should be taken to ensure that those handling patient-identifiable 
information - both clinical and non-clinical staff - are made fully aware of their 
responsibilities and obligations to respect patient confidentiality. 
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Principle 6 - Understand and comply with the law  
Every use of patient-identifiable information must be lawful. Someone in each 
organisation should be responsible for ensuring that the organisation complies 
with legal requirements. 
 
Caldicott Guardian for NHS Greater Glasgow & Clyde 
 
Robin Wright 
Director of Health, Information & Technology 
Greater Glasgow & Clyde NHS Board 
J B Russell House 
Gartnavel Royal Hospital 
Gt. Western Road 
Glasgow    
 
All queries in the first instance should be made to:   
 
Isobel Brown, Information Governance Manager Tel 0141 211 1790 or Email: 
Isobel.brown@ggc.scot.nhs.uk 
OR 
Ann McClumpha on Tel: 0141 201 4611 or E-Mail: 
ann.mcclumpha@ggc.scot.nhs.uk 
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Appendix H. Caldicott Guardian Approval Email Correspondence 
From: Kirsty Hendry [mailto:kirsty.hendry0@gmail.com]  
Sent: 13 March 2014 12:41 
To: Brown, Isobel 
Subject: Caldicott Guardian Approval application 
  
Dear Ms. Brown; 
Please find attached our application for Caldicott Guardian Approval. 
We are very grateful for your time and consideration.  
Regards, 
Kirsty 
 
Brown, Isobel <Isobel.Brown@ggc.scot.nhs.uk> Thu, Mar 20, 2014 at 11:36 AM
To: Kirsty Hendry <kirsty.hendry0@gmail.com> 
Cc: david.j.stott@glasgow.ac.uk, "McClumpha, Ann" 
<Ann.McClumpha@ggc.scot.nhs.uk> 
Hi Kirsty 
  
I have authorised this project on behalf of the Caldicott Guardian.  If you 
require a signed copy of the form returned to you, please let me know. 
  
Regards 
  
Isobel 
______________________________________________________________
____________________________________________________ 
Isobel Brown |Information Governance Manager | NHS Greater Glasgow & 
Clyde |  
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Western Infirmary| Management Building |  Dumbarton Road |  Glasgow |  G11 
6NT | 
T: 0141 211 1790 | E: isobel.brown@ggc.scot.nhs.uk |  W: www.nhsggc.org.uk 
  
O'Neill, Elaine <Elaine.O'Neill2@ggc.scot.nhs.uk> Mon, Mar 24, 2014 
at 2:52 PM
To: Kirsty Hendry <kirsty.hendry0@gmail.com> 
Hi Kirsty, 
  
In regards to this newer study - Are you treating it as a ‘service 
evaluation’? or is it ‘research’? 
  
Having Caldicott Guardian approval doesn’t mean that you don’t 
require Ethics and R&D approval, this is decided upon whether the 
study is ‘research’ or not. 
  
Kind Regards 
  
Elaine O'Neill 
Research Co-ordinator's Asst 
NHS Greater Glasgow & Clyde 
Research & Development 
Western Infirmary 
1st Floor, Tennent Building 
38 Church Street 
Glasgow 
G11 6NT 
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tel: 0141 232 9448 
int: 59448 
Web: www.nhsggc.org.uk/r&d  
 
David Stott <David.J.Stott@glasgow.ac.uk> Mon, Mar 31, 2014 at 1:49 PM
To: "Elaine.O'Neill2@ggc.scot.nhs.uk" <Elaine.O'Neill2@ggc.scot.nhs.uk> 
Cc: "kirsty.hendry0@gmail.com" <kirsty.hendry0@gmail.com> 
  
Hi Elaine, 
  
The primary purpose of Kirsty’s study is service evaluation, 
examining a package of current cognitive assessments 
recommended for routine use in older people in acute care with the 
aim of refining our process of assessment in NHS GG&C. However 
there is a research element to this work, as such a service 
evaluation is novel and the results will be of relevance not just 
within our organisation but also out-with GG&C. 
  
The general view of all the NHS clinicians included in this service 
evaluation is that this project comprises of systematic gathering 
and appraisal of routine health data and that Caldicott approval 
would be sufficient (and that ethics approval would not be 
required), however we would be grateful of you could provide a 
view from R&D on whether any further approvals will be required 
before we start. Given that there is a research element to this 
project we anticipate that Kirsty’s research passport will need to 
be updated to include this project. 
  
I have attached the approved Caldicott application. 
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I look forwards to hearing your views. 
  
Many thanks 
  
Yours sincerely 
David 
 
 
O'Neill, Elaine <Elaine.O'Neill2@ggc.scot.nhs.uk> Mon, Mar 31, 2014 
at 2:43 PM
To: Kirsty Hendry <kirsty.hendry0@gmail.com> 
Hi Kirsty, 
  
Erica Packard has followed up with Prof Stott this afternoon and 
they have agreed that it won’t be considered “Research” but will 
be processed as “Service Evaluation” which means you don’t 
require R&D approval, this also means it shouldn’t be added to 
your Research Passport. 
  
Kind Regards 
  
Elaine O'Neill 
Research Co-ordinator's Asst 
NHS Greater Glasgow & Clyde 
Research & Development 
Western Infirmary 
1st Floor, Tennent Building 
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38 Church Street 
Glasgow 
G11 6NT 
  
tel: 0141 232 9448 
int: 59448 
Web: www.nhsggc.org.uk/r&d  
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Appendix I. The Abbreviated Mental Test  
 
Questions Score (0 or 1) 
1. What is your age?  
2. What is the time to the nearest hour?  
3. Give the patient an address and ask him/her to repeat 
at end of test. E.g. 42 West Street 
 
4. What is the year   
5. What is the name of the hospital?  
6. Can the patient recognise two people? e.g. 
nurse/doctor 
 
7. What is your date of birth?   
8. In what year did WWI begin?  
9. Who is the present prime minister?  
10.Count backwards from 20 to 1 (no errors)  
 
* AMT 4 uses only items 1, 4, 5 & 7 
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Appendix J. The 4 A’s Test  
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Appendix K. The brief Confusion Assessment Method 
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Appendix L. Operationalised DSM 5 delirium diagnostic criteria 
used in this evaluation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DSM-V Delirium criteria / exclusions 
a) A disturbance in; 
i) Attention- reduced ability to direct, focus, sustain, and shift 
attention   yes   /   no   /   don’t know 
ii) Awareness (reduced orientation to the environment)            
                    yes   /   no   /   don’t 
know 
b) The disturbance; 
i) Develops over a short period of time (usually hours to a few 
days) 
yes   /  no   /   don’t know 
ii) Represents a change from baseline attention & awareness 
yes   /   no   /   don’t know 
iii) Tends to fluctuate in severity during the course of the day 
yes   /   no   /   don’t know 
c) An additional disturbance in cognition (e.g. memory deficit, 
disorientation, language, visuospatial ability, or perception).  
yes   /   no   /   don’t know 
d) Exclusions- The disturbance in criteria A and C are; 
i) Better explained by another pre-existing, established, or 
evolving neurocognitive disorder 
yes   /   no   /   don’t know 
ii) Occur in the context of a severely reduced level of arousal 
such as coma. 
yes   /   no   /   don’t know 
e) There is evidence from the history, physical examination or 
laboratory findings that the disturbance is a direct physiological 
consequence of another medical condition, substance intoxication 
or withdrawal (i.e. due to a drug of abuse or to a medication), or 
exposure to a toxin, or is due to multiple etiologies.  
 yes   /   no    
INITIAL DIAGNOSIS: Delirium - all items a, b, c and e ‘yes’, plus d ‘no’   
       No delirium - if any ‘no’ in a,b,c,or e or yes in d        
                       Possible delirium - if any ‘don’t know’ in a-d or ‘no’ in e.   
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Appendix M. Operationalised DSM IV dementia diagnostic criteria 
used in this evaluation. 
DSM-IV Dementia criteria / exclusions 
If prior diagnosis of dementia, please go to the diagnosis section below. 
a)  Memory impairment     yes   /   no   /   don’t know 
b) At least one of the following;  yes   /   no   /   don’t know 
Aphasia    Apraxia   Agnosia     
Disturbances in executive functioning   
c) The cognitive impairments must be severe enough to cause 
impairment in social and occupational functioning.  yes   /   no   /   
don’t know 
d) The decline must represent a decline from a previously higher level 
of functioning.     yes   /   no   /   don’t know 
e) Exclusion - The cognitive deficits occur exclusively during the course 
of a delirium.     
yes   /   no   /   don’t know 
 
INITIAL DIAGNOSIS: 
Dementia- prior diagnosis                      Dementia- a-d all ‘yes’ plus e ‘no’                                                                                                                                  
Possible Dementia- if any ‘don’t know’ plus other responses all consistent with 
dementia as above                                                                                                             
No Dementia- if any a-d ‘no’ or e ‘yes’                                                                           
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Appendix N. Screening test procedure split by informant and 
patient-based information. 
 
 
In
fo
rm
a
ti
o
n
 f
ro
m
 i
n
fo
rm
a
n
t 
1. Has the patient’s mental status 
changed from baseline? (informant 
– nurse) 
2. Has the patient’s mental status 
fluctuated since admission? 
(informant – nurse) 
3. What is the patient’s current mental 
status? (Richmond Agitation 
Sedation Scale) (informant - nurse) 
-------- 
4. SQiD question (informant- carer, 
relative or friend) 
 
 
P
a
ti
e
n
t 
 A
ss
e
ss
m
e
n
t 
6. Ask patient to spell “LUNCH” backwards 
7. Recite months backwards December > 
January 
8. 6 questions to assess disorganised thinking 
5. AMT-10  
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Appendix O. Relative/Carer single delirium screening data 
collection sheet.  
Relative/Friend/Carer Questionnaire 
Memory or confusion problems in older in-patients. 
 
• Problems with memory/confusion are very common in older people. Information 
from relative/friends or carers plays an important role in identifying such cognitive 
problems. We are evaluating ways of systematically gathering this information. 
 
• It would be very helpful if you could answer the following 2 questions. If you feel a 
different individual is better placed to answer these questions, please inform the 
ward nursing staff.  
 
Patient ID:   Ward:   Date: 
 
Relationship to patient:___________________________________ 
 
1. Has your relative/friend been more forgetful in the past 12 months, to the 
extent that it has significantly affected their daily life? (please circle your 
response)  
YES   NO  DON’T KNOW 
 
2. Do you think your relative/friend has been more confused lately? (please 
circle your response) 
   
YES   NO  DON’T KNOW 
 
Please leave the completed questionnaire with the ward nursing staff 
-Thank you very much for your time- 
 
 
Prof. David J Stott, Dr. Pam Fraser, Dr. Anne-Louise Cunnington, Dr. Jennifer Burns, Dr. 
Terry Quinn, Dr. Hazel Miller, Dr. Craig Harrow
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